{
 "cells": [
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# <font color = red> Kaggle_COVID-19 Week 2 Task "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "import numpy as np \n",
    "import pandas as pd \n",
    "import nltk\n",
    "import re\n",
    "from datetime import datetime"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "C:\\Users\\Celine\\Desktop\\UNH\\9-1\\902\\CORD-19-research-challenge\n"
     ]
    }
   ],
   "source": [
    "cd \"C:\\Users\\Celine\\Desktop\\UNH\\9-1\\902\\CORD-19-research-challenge\""
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(29315, 5)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>paper_id</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>body_text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>0015023cc06b5362d332b3baf348d11567ca2fbb</td>\n",
       "      <td>The RNA pseudoknots in foot-and-mouth disease ...</td>\n",
       "      <td>word count: 194 22 Text word count: 5168 23 24...</td>\n",
       "      <td>VP3, and VP0 (which is further processed to VP...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>004f0f8bb66cf446678dc13cf2701feec4f36d76</td>\n",
       "      <td>Healthcare-resource-adjusted vulnerabilities t...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The 2019-nCoV epidemic has spread across China...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>00d16927588fb04d4be0e6b269fc02f0d3c2aa7b</td>\n",
       "      <td>Real-time, MinION-based, amplicon sequencing f...</td>\n",
       "      <td>Infectious bronchitis (IB) causes significant ...</td>\n",
       "      <td>Infectious bronchitis (IB), which is caused by...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>0139ea4ca580af99b602c6435368e7fdbefacb03</td>\n",
       "      <td>A Combined Evidence Approach to Prioritize Nip...</td>\n",
       "      <td>Nipah Virus (NiV) came into limelight recently...</td>\n",
       "      <td>Nipah is an infectious negative-sense single-s...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>013d9d1cba8a54d5d3718c229b812d7cf91b6c89</td>\n",
       "      <td>Assessing spread risk of Wuhan novel coronavir...</td>\n",
       "      <td>Background: A novel coronavirus (2019-nCoV) em...</td>\n",
       "      <td>In December 2019, a cluster of patients with p...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0                                  paper_id  \\\n",
       "0           0  0015023cc06b5362d332b3baf348d11567ca2fbb   \n",
       "1           1  004f0f8bb66cf446678dc13cf2701feec4f36d76   \n",
       "2           2  00d16927588fb04d4be0e6b269fc02f0d3c2aa7b   \n",
       "3           3  0139ea4ca580af99b602c6435368e7fdbefacb03   \n",
       "4           4  013d9d1cba8a54d5d3718c229b812d7cf91b6c89   \n",
       "\n",
       "                                               title  \\\n",
       "0  The RNA pseudoknots in foot-and-mouth disease ...   \n",
       "1  Healthcare-resource-adjusted vulnerabilities t...   \n",
       "2  Real-time, MinION-based, amplicon sequencing f...   \n",
       "3  A Combined Evidence Approach to Prioritize Nip...   \n",
       "4  Assessing spread risk of Wuhan novel coronavir...   \n",
       "\n",
       "                                            abstract  \\\n",
       "0  word count: 194 22 Text word count: 5168 23 24...   \n",
       "1                                                NaN   \n",
       "2  Infectious bronchitis (IB) causes significant ...   \n",
       "3  Nipah Virus (NiV) came into limelight recently...   \n",
       "4  Background: A novel coronavirus (2019-nCoV) em...   \n",
       "\n",
       "                                           body_text  \n",
       "0  VP3, and VP0 (which is further processed to VP...  \n",
       "1  The 2019-nCoV epidemic has spread across China...  \n",
       "2  Infectious bronchitis (IB), which is caused by...  \n",
       "3  Nipah is an infectious negative-sense single-s...  \n",
       "4  In December 2019, a cluster of patients with p...  "
      ]
     },
     "execution_count": 10,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_all= pd.read_csv(\"df_all.csv\")\n",
    "print(df_all.shape)\n",
    "df_all.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(44220, 15)\n",
      "Index(['sha', 'source_x', 'title', 'doi', 'pmcid', 'pubmed_id', 'license',\n",
      "       'abstract', 'publish_time', 'authors', 'journal',\n",
      "       'Microsoft Academic Paper ID', 'WHO #Covidence', 'has_full_text',\n",
      "       'full_text_file'],\n",
      "      dtype='object')\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>sha</th>\n",
       "      <th>source_x</th>\n",
       "      <th>title</th>\n",
       "      <th>doi</th>\n",
       "      <th>pmcid</th>\n",
       "      <th>pubmed_id</th>\n",
       "      <th>license</th>\n",
       "      <th>abstract</th>\n",
       "      <th>publish_time</th>\n",
       "      <th>authors</th>\n",
       "      <th>journal</th>\n",
       "      <th>Microsoft Academic Paper ID</th>\n",
       "      <th>WHO #Covidence</th>\n",
       "      <th>has_full_text</th>\n",
       "      <th>full_text_file</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NaN</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>Intrauterine virus infections and congenital h...</td>\n",
       "      <td>10.1016/0002-8703(72)90077-4</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4361535.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>Abstract The etiologic basis for the vast majo...</td>\n",
       "      <td>1972-12-31</td>\n",
       "      <td>Overall, James C.</td>\n",
       "      <td>American Heart Journal</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NaN</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>Coronaviruses in Balkan nephritis</td>\n",
       "      <td>10.1016/0002-8703(80)90355-5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6243850.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1980-03-31</td>\n",
       "      <td>Georgescu, Leonida; Diosi, Peter; Buţiu, Ioan;...</td>\n",
       "      <td>American Heart Journal</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NaN</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>Cigarette smoking and coronary heart disease: ...</td>\n",
       "      <td>10.1016/0002-8703(80)90356-7</td>\n",
       "      <td>NaN</td>\n",
       "      <td>7355701.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1980-03-31</td>\n",
       "      <td>Friedman, Gary D</td>\n",
       "      <td>American Heart Journal</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>aecbc613ebdab36753235197ffb4f35734b5ca63</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>Clinical and immunologic studies in identical ...</td>\n",
       "      <td>10.1016/0002-9343(73)90176-9</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4579077.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>Abstract Middle-aged female identical twins, o...</td>\n",
       "      <td>1973-08-31</td>\n",
       "      <td>Brunner, Carolyn M.; Horwitz, David A.; Shann,...</td>\n",
       "      <td>The American Journal of Medicine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>custom_license</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NaN</td>\n",
       "      <td>Elsevier</td>\n",
       "      <td>Epidemiology of community-acquired respiratory...</td>\n",
       "      <td>10.1016/0002-9343(85)90361-4</td>\n",
       "      <td>NaN</td>\n",
       "      <td>4014285.0</td>\n",
       "      <td>els-covid</td>\n",
       "      <td>Abstract Upper respiratory tract infections ar...</td>\n",
       "      <td>1985-06-28</td>\n",
       "      <td>Garibaldi, Richard A.</td>\n",
       "      <td>The American Journal of Medicine</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>False</td>\n",
       "      <td>custom_license</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                        sha  source_x  \\\n",
       "0                                       NaN  Elsevier   \n",
       "1                                       NaN  Elsevier   \n",
       "2                                       NaN  Elsevier   \n",
       "3  aecbc613ebdab36753235197ffb4f35734b5ca63  Elsevier   \n",
       "4                                       NaN  Elsevier   \n",
       "\n",
       "                                               title  \\\n",
       "0  Intrauterine virus infections and congenital h...   \n",
       "1                  Coronaviruses in Balkan nephritis   \n",
       "2  Cigarette smoking and coronary heart disease: ...   \n",
       "3  Clinical and immunologic studies in identical ...   \n",
       "4  Epidemiology of community-acquired respiratory...   \n",
       "\n",
       "                            doi pmcid  pubmed_id    license  \\\n",
       "0  10.1016/0002-8703(72)90077-4   NaN  4361535.0  els-covid   \n",
       "1  10.1016/0002-8703(80)90355-5   NaN  6243850.0  els-covid   \n",
       "2  10.1016/0002-8703(80)90356-7   NaN  7355701.0  els-covid   \n",
       "3  10.1016/0002-9343(73)90176-9   NaN  4579077.0  els-covid   \n",
       "4  10.1016/0002-9343(85)90361-4   NaN  4014285.0  els-covid   \n",
       "\n",
       "                                            abstract publish_time  \\\n",
       "0  Abstract The etiologic basis for the vast majo...   1972-12-31   \n",
       "1                                                NaN   1980-03-31   \n",
       "2                                                NaN   1980-03-31   \n",
       "3  Abstract Middle-aged female identical twins, o...   1973-08-31   \n",
       "4  Abstract Upper respiratory tract infections ar...   1985-06-28   \n",
       "\n",
       "                                             authors  \\\n",
       "0                                  Overall, James C.   \n",
       "1  Georgescu, Leonida; Diosi, Peter; Buţiu, Ioan;...   \n",
       "2                                   Friedman, Gary D   \n",
       "3  Brunner, Carolyn M.; Horwitz, David A.; Shann,...   \n",
       "4                              Garibaldi, Richard A.   \n",
       "\n",
       "                            journal  Microsoft Academic Paper ID  \\\n",
       "0            American Heart Journal                          NaN   \n",
       "1            American Heart Journal                          NaN   \n",
       "2            American Heart Journal                          NaN   \n",
       "3  The American Journal of Medicine                          NaN   \n",
       "4  The American Journal of Medicine                          NaN   \n",
       "\n",
       "  WHO #Covidence  has_full_text  full_text_file  \n",
       "0            NaN          False  custom_license  \n",
       "1            NaN          False  custom_license  \n",
       "2            NaN          False  custom_license  \n",
       "3            NaN           True  custom_license  \n",
       "4            NaN          False  custom_license  "
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "metadata = pd.read_csv(\"metadata.csv\")\n",
    "print(metadata.shape)\n",
    "print(metadata.columns)\n",
    "metadata.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>paper_id</th>\n",
       "      <th>title_x</th>\n",
       "      <th>abstract_x</th>\n",
       "      <th>body_text</th>\n",
       "      <th>sha</th>\n",
       "      <th>source_x</th>\n",
       "      <th>title_y</th>\n",
       "      <th>doi</th>\n",
       "      <th>pmcid</th>\n",
       "      <th>pubmed_id</th>\n",
       "      <th>license</th>\n",
       "      <th>abstract_y</th>\n",
       "      <th>publish_time</th>\n",
       "      <th>authors</th>\n",
       "      <th>journal</th>\n",
       "      <th>Microsoft Academic Paper ID</th>\n",
       "      <th>WHO #Covidence</th>\n",
       "      <th>has_full_text</th>\n",
       "      <th>full_text_file</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>0015023cc06b5362d332b3baf348d11567ca2fbb</td>\n",
       "      <td>The RNA pseudoknots in foot-and-mouth disease ...</td>\n",
       "      <td>word count: 194 22 Text word count: 5168 23 24...</td>\n",
       "      <td>VP3, and VP0 (which is further processed to VP...</td>\n",
       "      <td>0015023cc06b5362d332b3baf348d11567ca2fbb</td>\n",
       "      <td>biorxiv</td>\n",
       "      <td>The RNA pseudoknots in foot-and-mouth disease ...</td>\n",
       "      <td>10.1101/2020.01.10.901801</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>biorxiv</td>\n",
       "      <td>The positive stranded RNA genomes of picornavi...</td>\n",
       "      <td>2020-01-11</td>\n",
       "      <td>Ward, J. C. J.; Lasecka-Dykes, L.; Neil, C.; A...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>biorxiv_medrxiv</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>004f0f8bb66cf446678dc13cf2701feec4f36d76</td>\n",
       "      <td>Healthcare-resource-adjusted vulnerabilities t...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The 2019-nCoV epidemic has spread across China...</td>\n",
       "      <td>004f0f8bb66cf446678dc13cf2701feec4f36d76</td>\n",
       "      <td>medrxiv</td>\n",
       "      <td>Healthcare-resource-adjusted vulnerabilities t...</td>\n",
       "      <td>10.1101/2020.02.11.20022111</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>medrvix</td>\n",
       "      <td>We integrate the human movement and healthcare...</td>\n",
       "      <td>2020-02-12</td>\n",
       "      <td>Hanchu Zhou; Jianan Yang; Kaichen Tang; Qingpe...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>biorxiv_medrxiv</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>00d16927588fb04d4be0e6b269fc02f0d3c2aa7b</td>\n",
       "      <td>Real-time, MinION-based, amplicon sequencing f...</td>\n",
       "      <td>Infectious bronchitis (IB) causes significant ...</td>\n",
       "      <td>Infectious bronchitis (IB), which is caused by...</td>\n",
       "      <td>00d16927588fb04d4be0e6b269fc02f0d3c2aa7b</td>\n",
       "      <td>biorxiv</td>\n",
       "      <td>Real-time, MinION-based, amplicon sequencing f...</td>\n",
       "      <td>10.1101/634600</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>biorxiv</td>\n",
       "      <td>Infectious bronchitis (IB) causes significant ...</td>\n",
       "      <td>2019-05-10</td>\n",
       "      <td>Butt, S. L.; Erwood, E. C.; Zhang, J.; Sellers...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>biorxiv_medrxiv</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>0139ea4ca580af99b602c6435368e7fdbefacb03</td>\n",
       "      <td>A Combined Evidence Approach to Prioritize Nip...</td>\n",
       "      <td>Nipah Virus (NiV) came into limelight recently...</td>\n",
       "      <td>Nipah is an infectious negative-sense single-s...</td>\n",
       "      <td>0139ea4ca580af99b602c6435368e7fdbefacb03</td>\n",
       "      <td>biorxiv</td>\n",
       "      <td>A Combined Evidence Approach to Prioritize Nip...</td>\n",
       "      <td>10.1101/2020.03.12.977918</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>biorxiv</td>\n",
       "      <td>AbstractBackgroundNipah Virus (NiV) came into ...</td>\n",
       "      <td>2020-03-12</td>\n",
       "      <td>Nishi Kumari; Ayush Upadhyay; Kishan Kalia; Ra...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>biorxiv_medrxiv</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>013d9d1cba8a54d5d3718c229b812d7cf91b6c89</td>\n",
       "      <td>Assessing spread risk of Wuhan novel coronavir...</td>\n",
       "      <td>Background: A novel coronavirus (2019-nCoV) em...</td>\n",
       "      <td>In December 2019, a cluster of patients with p...</td>\n",
       "      <td>013d9d1cba8a54d5d3718c229b812d7cf91b6c89</td>\n",
       "      <td>medrxiv</td>\n",
       "      <td>Assessing spread risk of Wuhan novel coronavir...</td>\n",
       "      <td>10.1101/2020.02.04.20020479</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>medrvix</td>\n",
       "      <td>Background: A novel coronavirus (2019-nCoV) em...</td>\n",
       "      <td>2020-02-05</td>\n",
       "      <td>Shengjie Lai; Isaac Bogoch; Nick Ruktanonchai;...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>True</td>\n",
       "      <td>biorxiv_medrxiv</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0                                  paper_id  \\\n",
       "0           0  0015023cc06b5362d332b3baf348d11567ca2fbb   \n",
       "1           1  004f0f8bb66cf446678dc13cf2701feec4f36d76   \n",
       "2           2  00d16927588fb04d4be0e6b269fc02f0d3c2aa7b   \n",
       "3           3  0139ea4ca580af99b602c6435368e7fdbefacb03   \n",
       "4           4  013d9d1cba8a54d5d3718c229b812d7cf91b6c89   \n",
       "\n",
       "                                             title_x  \\\n",
       "0  The RNA pseudoknots in foot-and-mouth disease ...   \n",
       "1  Healthcare-resource-adjusted vulnerabilities t...   \n",
       "2  Real-time, MinION-based, amplicon sequencing f...   \n",
       "3  A Combined Evidence Approach to Prioritize Nip...   \n",
       "4  Assessing spread risk of Wuhan novel coronavir...   \n",
       "\n",
       "                                          abstract_x  \\\n",
       "0  word count: 194 22 Text word count: 5168 23 24...   \n",
       "1                                                NaN   \n",
       "2  Infectious bronchitis (IB) causes significant ...   \n",
       "3  Nipah Virus (NiV) came into limelight recently...   \n",
       "4  Background: A novel coronavirus (2019-nCoV) em...   \n",
       "\n",
       "                                           body_text  \\\n",
       "0  VP3, and VP0 (which is further processed to VP...   \n",
       "1  The 2019-nCoV epidemic has spread across China...   \n",
       "2  Infectious bronchitis (IB), which is caused by...   \n",
       "3  Nipah is an infectious negative-sense single-s...   \n",
       "4  In December 2019, a cluster of patients with p...   \n",
       "\n",
       "                                        sha source_x  \\\n",
       "0  0015023cc06b5362d332b3baf348d11567ca2fbb  biorxiv   \n",
       "1  004f0f8bb66cf446678dc13cf2701feec4f36d76  medrxiv   \n",
       "2  00d16927588fb04d4be0e6b269fc02f0d3c2aa7b  biorxiv   \n",
       "3  0139ea4ca580af99b602c6435368e7fdbefacb03  biorxiv   \n",
       "4  013d9d1cba8a54d5d3718c229b812d7cf91b6c89  medrxiv   \n",
       "\n",
       "                                             title_y  \\\n",
       "0  The RNA pseudoknots in foot-and-mouth disease ...   \n",
       "1  Healthcare-resource-adjusted vulnerabilities t...   \n",
       "2  Real-time, MinION-based, amplicon sequencing f...   \n",
       "3  A Combined Evidence Approach to Prioritize Nip...   \n",
       "4  Assessing spread risk of Wuhan novel coronavir...   \n",
       "\n",
       "                           doi pmcid  pubmed_id  license  \\\n",
       "0    10.1101/2020.01.10.901801   NaN        NaN  biorxiv   \n",
       "1  10.1101/2020.02.11.20022111   NaN        NaN  medrvix   \n",
       "2               10.1101/634600   NaN        NaN  biorxiv   \n",
       "3    10.1101/2020.03.12.977918   NaN        NaN  biorxiv   \n",
       "4  10.1101/2020.02.04.20020479   NaN        NaN  medrvix   \n",
       "\n",
       "                                          abstract_y publish_time  \\\n",
       "0  The positive stranded RNA genomes of picornavi...   2020-01-11   \n",
       "1  We integrate the human movement and healthcare...   2020-02-12   \n",
       "2  Infectious bronchitis (IB) causes significant ...   2019-05-10   \n",
       "3  AbstractBackgroundNipah Virus (NiV) came into ...   2020-03-12   \n",
       "4  Background: A novel coronavirus (2019-nCoV) em...   2020-02-05   \n",
       "\n",
       "                                             authors journal  \\\n",
       "0  Ward, J. C. J.; Lasecka-Dykes, L.; Neil, C.; A...     NaN   \n",
       "1  Hanchu Zhou; Jianan Yang; Kaichen Tang; Qingpe...     NaN   \n",
       "2  Butt, S. L.; Erwood, E. C.; Zhang, J.; Sellers...     NaN   \n",
       "3  Nishi Kumari; Ayush Upadhyay; Kishan Kalia; Ra...     NaN   \n",
       "4  Shengjie Lai; Isaac Bogoch; Nick Ruktanonchai;...     NaN   \n",
       "\n",
       "   Microsoft Academic Paper ID WHO #Covidence  has_full_text   full_text_file  \n",
       "0                          NaN            NaN           True  biorxiv_medrxiv  \n",
       "1                          NaN            NaN           True  biorxiv_medrxiv  \n",
       "2                          NaN            NaN           True  biorxiv_medrxiv  \n",
       "3                          NaN            NaN           True  biorxiv_medrxiv  \n",
       "4                          NaN            NaN           True  biorxiv_medrxiv  "
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "merge = pd.merge(df_all, metadata, how='inner', left_on=\"paper_id\", right_on='sha')\n",
    "merge.shape\n",
    "merge.head()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(27690, 3)\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>paper_id</th>\n",
       "      <th>title_x</th>\n",
       "      <th>body_text</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0015023cc06b5362d332b3baf348d11567ca2fbb</td>\n",
       "      <td>The RNA pseudoknots in foot-and-mouth disease ...</td>\n",
       "      <td>VP3, and VP0 (which is further processed to VP...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>004f0f8bb66cf446678dc13cf2701feec4f36d76</td>\n",
       "      <td>Healthcare-resource-adjusted vulnerabilities t...</td>\n",
       "      <td>The 2019-nCoV epidemic has spread across China...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>00d16927588fb04d4be0e6b269fc02f0d3c2aa7b</td>\n",
       "      <td>Real-time, MinION-based, amplicon sequencing f...</td>\n",
       "      <td>Infectious bronchitis (IB), which is caused by...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>0139ea4ca580af99b602c6435368e7fdbefacb03</td>\n",
       "      <td>A Combined Evidence Approach to Prioritize Nip...</td>\n",
       "      <td>Nipah is an infectious negative-sense single-s...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>013d9d1cba8a54d5d3718c229b812d7cf91b6c89</td>\n",
       "      <td>Assessing spread risk of Wuhan novel coronavir...</td>\n",
       "      <td>In December 2019, a cluster of patients with p...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                   paper_id  \\\n",
       "0  0015023cc06b5362d332b3baf348d11567ca2fbb   \n",
       "1  004f0f8bb66cf446678dc13cf2701feec4f36d76   \n",
       "2  00d16927588fb04d4be0e6b269fc02f0d3c2aa7b   \n",
       "3  0139ea4ca580af99b602c6435368e7fdbefacb03   \n",
       "4  013d9d1cba8a54d5d3718c229b812d7cf91b6c89   \n",
       "\n",
       "                                             title_x  \\\n",
       "0  The RNA pseudoknots in foot-and-mouth disease ...   \n",
       "1  Healthcare-resource-adjusted vulnerabilities t...   \n",
       "2  Real-time, MinION-based, amplicon sequencing f...   \n",
       "3  A Combined Evidence Approach to Prioritize Nip...   \n",
       "4  Assessing spread risk of Wuhan novel coronavir...   \n",
       "\n",
       "                                           body_text  \n",
       "0  VP3, and VP0 (which is further processed to VP...  \n",
       "1  The 2019-nCoV epidemic has spread across China...  \n",
       "2  Infectious bronchitis (IB), which is caused by...  \n",
       "3  Nipah is an infectious negative-sense single-s...  \n",
       "4  In December 2019, a cluster of patients with p...  "
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "#extra step for getting different dataset \n",
    "extract_data =merge[[\"paper_id\",\"title_x\", \"body_text\"]]\n",
    "print(extract_data.shape)\n",
    "extract_data.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 3. Data processing step (Tokenization ,Remove punctuation and special characters ,lowercase)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "# tokenize words for the search engine \n",
    "tokenizer = RegexpTokenizer(r'\\w+')\n",
    "stemmer = PorterStemmer() \n",
    "stop_words = set(stopwords.words('english'))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "# word tokenize dependencies \n",
    "import nltk\n",
    "# nltk.download('stopwords')\n",
    "#nltk.download('punkt')\n",
    "from nltk import word_tokenize\n",
    "from nltk import wordpunct_tokenize\n",
    "from nltk.corpus import stopwords\n",
    "from nltk.tokenize import RegexpTokenizer\n",
    "from nltk.stem import PorterStemmer\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "#clutering function\n",
    "from sklearn.cluster import KMeans\n",
    "\n",
    "## DTM Makers ####\n",
    "from sklearn.feature_extraction.text import CountVectorizer\n",
    "from sklearn.feature_extraction.text import TfidfTransformer"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package punkt to\n",
      "[nltk_data]     C:\\Users\\Celine\\AppData\\Roaming\\nltk_data...\n",
      "[nltk_data]   Unzipping tokenizers\\punkt.zip.\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": []
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 4. The objective is to create a Search engine to find papers based on key words. \n",
    "\n",
    "Start with search one word \n",
    "\n",
    "Use Regular expressions to find one word\n",
    "\n",
    "A combination of words (do it on body text)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Search:covid\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\ProgramData\\Anaconda3\\lib\\site-packages\\ipykernel_launcher.py:35: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: https://pandas.pydata.org/pandas-docs/stable/user_guide/indexing.html#returning-a-view-versus-a-copy\n"
     ]
    }
   ],
   "source": [
    "#tNote: his part of code is take from Josh\n",
    "\n",
    "input_word = input(\"Search:\")\n",
    "\n",
    "stop_words = set(stopwords.words('english'))\n",
    "input_word = input_word.lower().split(\" \")\n",
    "input_word = [word for word in input_word if word not in stop_words]\n",
    "\n",
    "\n",
    "word_count = []\n",
    "drops = []\n",
    "\n",
    "#input pattern \n",
    "pattern = ''\n",
    "for word in input_word:\n",
    "    word = word +\"|\"  # means word_a or word_b or word_c whatever word in the sentence  \n",
    "    pattern = pattern +word \n",
    "    \n",
    "#search whole document\n",
    "\n",
    "for i,j in enumerate(df_all.body_text):\n",
    "    j = j.lower()\n",
    "    match =re.findall(\"{}\".format(pattern), j)\n",
    "#     match = re.match(pattern, j)\n",
    "    z = 0\n",
    "    for word in match:\n",
    "         if word != '': \n",
    "                z+=1\n",
    "    if z > 0:\n",
    "        word_count.append(z)\n",
    "        drops.append(True)\n",
    "    else:\n",
    "        drops.append(False)\n",
    "\n",
    "\n",
    "final_df = df_all[drops] # condition only pick the document with searching words \n",
    "final_df['word_counts'] = word_count \n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>paper_id</th>\n",
       "      <th>title</th>\n",
       "      <th>abstract</th>\n",
       "      <th>body_text</th>\n",
       "      <th>word_counts</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>45</th>\n",
       "      <td>45</td>\n",
       "      <td>0e38333bff68345492526fd39b70d1b18969cb83</td>\n",
       "      <td>Deep Learning-based Detection for COVID-19 fro...</td>\n",
       "      <td>Accurate and rapid diagnosis of COVID-19 suspe...</td>\n",
       "      <td>huge amount of efforts for radiologists, which...</td>\n",
       "      <td>62</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>47</th>\n",
       "      <td>47</td>\n",
       "      <td>0eee9760aee0ca2fdf8d1d215c3689d5f8d84df5</td>\n",
       "      <td>Prevalence and clinical features of 2019 novel...</td>\n",
       "      <td>Background With the spread of COVID-19 from Wu...</td>\n",
       "      <td>The first cluster of cases of pneumonia with u...</td>\n",
       "      <td>58</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>308</th>\n",
       "      <td>308</td>\n",
       "      <td>57a86b3acd182c955877afd4792719a4e9a0ac32</td>\n",
       "      <td>Cross-sectional Study Affiliations</td>\n",
       "      <td>Background: So far, the psychological impact o...</td>\n",
       "      <td>Since December 2019, coronavirus disease 2019 ...</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10982</th>\n",
       "      <td>10982</td>\n",
       "      <td>0f15655bda78c3a62a03a19d8028f8f5cf5a1ef5</td>\n",
       "      <td>Clinical characteristics and intrauterine vert...</td>\n",
       "      <td>Background Previous studies on the pneumonia o...</td>\n",
       "      <td>The type of pneumonia caused by the 2019 novel...</td>\n",
       "      <td>56</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>746</th>\n",
       "      <td>746</td>\n",
       "      <td>de055f09fef2776bc78bac5d58c4131301b2025f</td>\n",
       "      <td>Impacts of Social and Economic Factors on the ...</td>\n",
       "      <td>This paper examines the role of various socioe...</td>\n",
       "      <td>Several clusters of patients with pneumonia of...</td>\n",
       "      <td>51</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13376</th>\n",
       "      <td>13376</td>\n",
       "      <td>32bc6e6fdbe51b64640357919dc17f29e9b0ebb1</td>\n",
       "      <td>Psychological crisis intervention during the o...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The outbreak of new coronavirus pneumonia (NCP...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13565</th>\n",
       "      <td>13565</td>\n",
       "      <td>35be4bfe3809797eb672c5f54b37d3cbd996db74</td>\n",
       "      <td>Highlights Risk factors control in atheroscler...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>In Taiwan, atherosclerotic cardiovascular dise...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13600</th>\n",
       "      <td>13600</td>\n",
       "      <td>364563f6674928b4a6386e656dd217d37e656645</td>\n",
       "      <td>Journal Pre-proof Estimation of the asymptomat...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This is a PDF file of an article that has unde...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14316</th>\n",
       "      <td>14316</td>\n",
       "      <td>40dabecefc2f0a2b750e000d1c15cca57a3f7dd4</td>\n",
       "      <td>ANIMAL VIRUSES OF ECONOMIC IMPORTANCE: GENETIC...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This article is intended as a review of the re...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29285</th>\n",
       "      <td>29285</td>\n",
       "      <td>fc520c33ec7052adb24af0b3bbb43526f92f6eac</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Li Wenliang, a face to the frontline healthcar...</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>665 rows × 6 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "       Unnamed: 0                                  paper_id  \\\n",
       "45             45  0e38333bff68345492526fd39b70d1b18969cb83   \n",
       "47             47  0eee9760aee0ca2fdf8d1d215c3689d5f8d84df5   \n",
       "308           308  57a86b3acd182c955877afd4792719a4e9a0ac32   \n",
       "10982       10982  0f15655bda78c3a62a03a19d8028f8f5cf5a1ef5   \n",
       "746           746  de055f09fef2776bc78bac5d58c4131301b2025f   \n",
       "...           ...                                       ...   \n",
       "13376       13376  32bc6e6fdbe51b64640357919dc17f29e9b0ebb1   \n",
       "13565       13565  35be4bfe3809797eb672c5f54b37d3cbd996db74   \n",
       "13600       13600  364563f6674928b4a6386e656dd217d37e656645   \n",
       "14316       14316  40dabecefc2f0a2b750e000d1c15cca57a3f7dd4   \n",
       "29285       29285  fc520c33ec7052adb24af0b3bbb43526f92f6eac   \n",
       "\n",
       "                                                   title  \\\n",
       "45     Deep Learning-based Detection for COVID-19 fro...   \n",
       "47     Prevalence and clinical features of 2019 novel...   \n",
       "308                   Cross-sectional Study Affiliations   \n",
       "10982  Clinical characteristics and intrauterine vert...   \n",
       "746    Impacts of Social and Economic Factors on the ...   \n",
       "...                                                  ...   \n",
       "13376  Psychological crisis intervention during the o...   \n",
       "13565  Highlights Risk factors control in atheroscler...   \n",
       "13600  Journal Pre-proof Estimation of the asymptomat...   \n",
       "14316  ANIMAL VIRUSES OF ECONOMIC IMPORTANCE: GENETIC...   \n",
       "29285                                                NaN   \n",
       "\n",
       "                                                abstract  \\\n",
       "45     Accurate and rapid diagnosis of COVID-19 suspe...   \n",
       "47     Background With the spread of COVID-19 from Wu...   \n",
       "308    Background: So far, the psychological impact o...   \n",
       "10982  Background Previous studies on the pneumonia o...   \n",
       "746    This paper examines the role of various socioe...   \n",
       "...                                                  ...   \n",
       "13376                                                NaN   \n",
       "13565                                                NaN   \n",
       "13600                                                NaN   \n",
       "14316                                                NaN   \n",
       "29285                                                NaN   \n",
       "\n",
       "                                               body_text  word_counts  \n",
       "45     huge amount of efforts for radiologists, which...           62  \n",
       "47     The first cluster of cases of pneumonia with u...           58  \n",
       "308    Since December 2019, coronavirus disease 2019 ...           56  \n",
       "10982  The type of pneumonia caused by the 2019 novel...           56  \n",
       "746    Several clusters of patients with pneumonia of...           51  \n",
       "...                                                  ...          ...  \n",
       "13376  The outbreak of new coronavirus pneumonia (NCP...            1  \n",
       "13565  In Taiwan, atherosclerotic cardiovascular dise...            1  \n",
       "13600  This is a PDF file of an article that has unde...            1  \n",
       "14316  This article is intended as a review of the re...            1  \n",
       "29285  Li Wenliang, a face to the frontline healthcar...            1  \n",
       "\n",
       "[665 rows x 6 columns]"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "final_df.sort_values('word_counts',ascending=False)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 5. Cluster papers (K-mean, DBScan)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['i', 'me', 'my', 'myself', 'we', 'our', 'ours', 'ourselves', 'you', \"you're\", \"you've\", \"you'll\", \"you'd\", 'your', 'yours', 'yourself', 'yourselves', 'he', 'him', 'his', 'himself', 'she', \"she's\", 'her', 'hers', 'herself', 'it', \"it's\", 'its', 'itself', 'they', 'them', 'their', 'theirs', 'themselves', 'what', 'which', 'who', 'whom', 'this', 'that', \"that'll\", 'these', 'those', 'am', 'is', 'are', 'was', 'were', 'be', 'been', 'being', 'have', 'has', 'had', 'having', 'do', 'does', 'did', 'doing', 'a', 'an', 'the', 'and', 'but', 'if', 'or', 'because', 'as', 'until', 'while', 'of', 'at', 'by', 'for', 'with', 'about', 'against', 'between', 'into', 'through', 'during', 'before', 'after', 'above', 'below', 'to', 'from', 'up', 'down', 'in', 'out', 'on', 'off', 'over', 'under', 'again', 'further', 'then', 'once', 'here', 'there', 'when', 'where', 'why', 'how', 'all', 'any', 'both', 'each', 'few', 'more', 'most', 'other', 'some', 'such', 'no', 'nor', 'not', 'only', 'own', 'same', 'so', 'than', 'too', 'very', 's', 't', 'can', 'will', 'just', 'don', \"don't\", 'should', \"should've\", 'now', 'd', 'll', 'm', 'o', 're', 've', 'y', 'ain', 'aren', \"aren't\", 'couldn', \"couldn't\", 'didn', \"didn't\", 'doesn', \"doesn't\", 'hadn', \"hadn't\", 'hasn', \"hasn't\", 'haven', \"haven't\", 'isn', \"isn't\", 'ma', 'mightn', \"mightn't\", 'mustn', \"mustn't\", 'needn', \"needn't\", 'shan', \"shan't\", 'shouldn', \"shouldn't\", 'wasn', \"wasn't\", 'weren', \"weren't\", 'won', \"won't\", 'wouldn', \"wouldn't\", '#', '$', '%', '&', \"'\", \"''\", \"'s\", '(', ')', '*', '+', ',', '-', '.', '..', '...', '.a', '.in', '.the', '.we', '/', '//doi.org/10', '//doi.org/10.1101', '//doi.org/10.1101/2020.02', '//doi.org/10.1101/2020.03', '/2020', '/l', '0', '0.001', '0.01', '0.05', '0.5', '0.8', '0.9', '1', '1.', '1.5', '10', '100', '1000', '11', '1101', '12', '120', '13', '14', '15', '16', '17', '18', '19', '21', '22', '23', '24', '25', '26', '27', '28', '29', '2a', '2b', '3', '30', '300', '31', '32', '33', '34', '35', '36', '37', '38', '39', '3a', '3b', '3d', '4', '4.0', '40', '41', '42', '43', '44', '45', '46', '47', '48', '49', '5', '50', '500', '51', '52', '53', '54', '55', '56', '57', '58', '59', '6', '60', '61', '62', '63', '64', '65', '66', '67', '68', '69', '7', '70', '71', '72', '73', '74', '75', '77', '78', '79', '8', '80', '81', '82', '83', '85', '86', '88', '9', '90', '92', '93', '95', '96', '98', '99', ':', ';', '<', '=', '>', '?', '[', ']', '``', '±', '×', 'à', 'α', 'β', 'γ', 'δ', 'θ', 'τ', '•', '′', '−', '≤']\n"
     ]
    }
   ],
   "source": [
    "# name stop words in document \n",
    "en_stop = stopwords.words('english')\n",
    "\n",
    "#extend the stopword list\n",
    "en_stop.extend(['#', '$', '%', '&', \"'\", \"''\", \"'s\", '(', ')', '*', '+', ',', '-', '.', '..', '...', '.a', '.in', '.the', '.we', '/', '//doi.org/10', '//doi.org/10.1101', '//doi.org/10.1101/2020.02', '//doi.org/10.1101/2020.03', '/2020', '/l', '0', '0.001', '0.01', '0.05', '0.5', '0.8', '0.9', '1', '1.', '1.5', '10', '100', '1000', '11', '1101', '12', '120', '13', '14', '15', '16', '17', '18', '19','21', '22', '23', '24', '25', '26', '27', '28', '29', '2a', '2b', '3', '30', '300', '31', '32', '33', '34', '35', '36', '37', '38', '39', '3a', '3b', '3d', '4', '4.0', '40', '41', '42', '43', '44', '45', '46', '47', '48', '49', '5', '50', '500', '51', '52', '53', '54', '55', '56', '57', '58', '59', '6', '60', '61', '62', '63', '64', '65', '66', '67', '68', '69', '7', '70', '71', '72', '73', '74', '75', '77', '78', '79', '8', '80', '81', '82', '83', '85', '86', '88', '9', '90', '92', '93', '95', '96', '98', '99', ':', ';', '<', '=', '>', '?', '[', ']', '``','±', '×', 'à', 'α', 'β', 'γ', 'δ', 'θ', 'τ', '•', '′', '−', '≤'])\n",
    "print(en_stop)\n",
    "\n",
    "# name stemmer in document\n",
    "stemmer = PorterStemmer()\n",
    "\n",
    "# name tokenizer in document\n",
    "tokenizer = RegexpTokenizer(r'\\w+')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['The sudden outbreak of the new coronavirus (SARS-CoV-2) at the end of December 2019 poses a huge threat to human health worldwide. The SARS-CoV-2 virus causes severe respiratory disease that can quickly spread from person to person and in some cases lead to death.Researchers have found that the new SARS-CoV-2 and SARS coronaviruses invade human cells in target tissues in a similar manner via high-affinity binding to angiotensin-converting enzyme 2 (ACE2) [1] . In recent epidemiological investigations of the spread of the SARS-CoV-2 and a preliminary study of the clinical characteristics of this disease [2] [3] [4] [5] [6] , researchers have found that patients infected with the new coronavirus have severe symptoms similar to those of the SARS infection. The first batch of clinical data reports of SARS-CoV-2 infection cases in China revealed \"cytokine storms\" in critically ill patients [7, 8] . However, the mechanism of the viral infection and pathological changes in the immune system is still lacking. The sooner this information is added to the current clinical knowledge of these viruses, the better the control and treatment of this disease.Here, we present an automated topic-wise inference method called TWIRLS (Topic-wise inference engine of massive biomedical literatures) for processing the massive biomedical literature to summarize coronavirus host-related entities. TWIRLS is capable of collecting, classifying, and analyzing reported coronavirus studies to reveal these entities based on the distribution of specific genes in the text of the articles. By combining with general protein interaction data, links between certain functional cellular/physiological components can be inferred to fill the knowledge gaps on the probable mechanism of host pathological changes. eventually leads to acute lung injury in the host. Therefore, TWIRLS can be used to guide human researchers by providing further potential therapeutic target information for the treatment of acute viral lung injury based on the regulation of RAS.Coronavirus-study specific entities and host genes As of February 21, 2020, the PubMed database included 14,878 biomedical articles on coronaviruses. We obtained text data (called local samples) from all related articles on the coronavirus that had been peer reviewed and published by human experts, which included the title, abstracts, author and affiliation information (total 3,182,687 words). The goal of the literature mining was to identify host genes and entities that are relevant to coronavirus research and to establish connections between them. An entity can refers to a word or phrase of the concept name (including related concepts, e.g., virus structure and chemical composition, source of infection, and virus type). The gene names were defined using the mammalian official gene symbols in the Hugo Gene Naming Committee (HGNC) database. We directly retrieved 667 candidate genes from the local samples. By establishing a random distribution of one of the candidate genes in a control sample, the significance of this gene appearing in the local samples can be determined when the frequency of the current gene is an outlier of the random distribution of the control samples (see Methods for details). By calculating the odds ratio, we can also further determine the specificity of the association between this gene and the local samples. In this paper, we selected an odds ratio > 6 as the threshold for this judgment, which resulted in 123 coronavirus study-specific host genes (CSHGs).To determine the specificity of the entity, we made a choice between different texts in the local samples. We removed numbers, symbols, verbs, and garbled characters to obtain clean versions of the local samples. The coronavirus study-specific entities (CSSE) were then identified in only the clean texts containing CSHGs. Based on the clean selected samples, we next built a local dictionary of candidate CSSEs containing 49,293 words after deduplication. Before calculating the random distribution of each entity, we included the synonymous entities into a same entity number (including singular or plural words, active and passive forms, different tenses, suffixes that do not change the meaning, etc.). For example, synonymous entities such as coronaviral, coronavirus, coronaviruses were grouped into one entity as coronavirus and assigned the same number (see entity number in Table S1 , Sheet 1 first column). The previous method of merging synonymous entities was based on a dictionary [9, 10] , which not only relied on the integrity of the dictionary, but also required a long retrieval time. To automatically solve the synonymous entity problem, TWIRLS classifies similar strings based on whether there is a significant statistical association between the character blocks in a set of candidate entities including various synonymous entities (see Methods). After cleaning and processing, CSSEs were identified by TWIRLS using a similar method to that for CSHG as described above.For the candidate CSSE dictionary, a random distribution model for each entity was built by TWIRLS using the control samples. We identified 623 CSSEs (Table Sl, Sheet 1) based on the outliers discriminated by the random model and calculated odds ratio. For example, TWIRLS found 100 CSSEs close to ACE2, the receptor of SARS and SARS-CoV-2 viruses (see left panel in Figure 1 ). The size of the entity represents the relative distance to ACE2, with a larger size indicating a closer distance to ACE2. Additionally, we present the CSSE cloud of the human receptor gene DPP4 of the MERS virus (see right panel in Figure 1 ).Although TWIRLS only identified 623 CSSEs after collation, for human researchers, the information is scattered in words, which is limited for reconstructing understandable mechanistic models. Therefore, TWIRLS clusters CSSEs according to the rules defined by CSHG distribution, as genetic level research can accurately answer and solve physiological and pathological problems.TWIRLS first calculated the specific co-distribution between CSHGs in local samples, then determined the distance between each pair of CSSEs and performs dichotomy clustering according to the linkage relationship between CSSEs and CSHGs. This classified the 623 entities into 32 categories represented as C0-C31 (see category number in Table S1 , Sheet 1 second column). In addition, for each category, TWIRLS also cited the top ten most relevant references for human researchers (Table S2) . Therefore, in any category, according to the CSSE and the most relevant literature, we can quickly provide \"Labels of conclusion-drawn-by-human-researcher\" (HR Labels) for this category. This label outlines the most relevant research directions of the current entity category. For example, for category C3, the HR label is \"Neurotrophic Coronavirus Related to Immune-Mediated Demyelination\". We have summarized the HR labels for the 32 entity categories in Table 1 .The relative position of any CSHG to a certain CSSE can be estimated by TWIRLS (see Table S1 , the ranking matrix in Sheet 1). As each category contains different entities, we can determine whether a certain CSHG is significantly closer to each entity in the current category based on the ranking matrix between CSHG and CSSE. For example, the average distance between ACE2 and the 92 entities in category C5 is first calculated, then a random distribution model of the average distance between ACE2 and any of the 92 entities (3000-5000 times) is built, and finally, we determine if the average distance between ACE2 and entities in category C5 is significantly less than and deviates from the mean of the random distribution (Z score = -5.8416). The significance of each category associated with each CSHG is then scored by TWIRLS ranging between -10 and +10, with a smaller score indicating the current CSHG is more relevant to the current category (see the Z-score matrix in Table S1 , sheet 2). For an entity category, the associated CSHGs (e.g., Ci CSHGs, where i represents the category number) can thus be selected by a Z score <-3 (the Z scores describing the association between CSHG and any category is summarized in Sheet2 of Table S1 , and the category labels of all CSHGs are provided in Sheet 3).Specifically, Spike proteins (S proteins) of different coronaviruses recognize different receptor molecules on human cells, such as ACE2 (binds to Spike proteins in SARS and SARS-CoV-2 virus) and DPP4 (binds to Spike protein in MERS virus). We found that these two genes are assigned to the C5 category, which has a corresponding HR label of \"Spike protein (S) of coronavirus\", suggesting that TWIRLS can automatically provide an interface to summarize human findings and help human experts quickly understand the research directions and necessary knowledge in this field.The distribution and meaning of the data can be compared to specific expression values of CSHG under different conditions (here, the category is used as a condition). Therefore, based on the All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.02.24.20025437 doi: medRxiv preprint distribution of the pathway signatures, TWIRLS can recommend the most likely and least likely signaling pathways (Table 2) . On the other hand, TWIRLS can also recommend the most likely and least likely categories for each signaling pathway. As an example, Table 3 shows the signaling pathways most likely associated with category C3 with the most unlikely corresponding category.We coupled the data with gene interaction/regulation databases and constructed a generalized protein-protein interaction network (PPI network) among 119 genes out of the 123 CSHGs. We defined the direct interaction between two genes as a 1 degree (1 o ) interaction, and the indirect interaction connecting two genes through a gene as a 2 degree (2 o ) interaction. All the genes in the 1 o networks mined in the PPI database are shown in Figure 2 . The results after deduplication showed 2,004 pairs in the 119 CSHGs (see Table S1 , Sheet 4). As a control, the average interactions of 119 randomly selected genes in the database showed between 252 to 612 pairs (average 220.16, standard deviation 35.15). Compared to random genes, the regulatory connections between CSHGs were significantly enriched (Z score = 50.97).Those CSHGs associated with a certain category had much closer interactions. For example, CSHGs associated with category C3 (or associated with C5 or C10) were closer to each other in the 1 o networks (Figure 2 ), suggesting that TWIRLS can possibly highlight important research directions and biology systems involved in coronavirus-specific research and can provide reliable interfaces for further automatic inference.Several hub genes among the 119 CSHGs were further recommended by TWIRLS. Compared to a random sampling from all interactions recorded in the database, these hub genes had significantly increased numbers of interactions with the other 118 CSHGs. The recommended results showed that the three members of the IFITMs family (IFITM1-3) ranked first, second, and sixth among the top ten hub genes (CSSE cloud of the IFITMs family genes is shown in Figure 3 ; detailed ranking recommendation results are shown in Table S1 , Sheet 5). These IFITMs genes showed 115 interactions, accounting for 8.59% out of all 1,338 interactions of the 119 CSHGs. These IFITMs were significantly enriched in the local samples representing updated coronavirus-related All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.02. 24.20025437 doi: medRxiv preprint studies (average 0.03% in the control test of random samplings, p <1.5676e-61). The IFITMs family plays crucial roles in the induction of interferons during viral infections. Under the action of interferon, IFITMs disrupts intracellular cholesterol homeostasis and prevents the virus from entering the host cell [11] . However, TWIRLS did not directly associate IFITMs with any category, so we needed to provide more information so that TWIRLS can determine which part of these genes might be involved in the coronavirus infection and host body response.Combining with generalized interaction databases provides richer interactions and regulatory linkages. We extended the 119 CSHGs to their 2 o networks based on the interactions with higher likelihood of connections (Combined score> 800). The 2 o networks expanded the number of genes from 119 host genes to 3,494 genes that may be associated with coronavirus (see Table S1 , Sheet 6 with DPP4 [12] . The different distribution of these receptors in the respiratory tract results in different degrees of infection. Although the infection ability of MERS is lower than in SARS, the mortality is higher (in about one-third of patients) because of the deeper infection site [13] . Similar to the SARS virus, viral genomics and structural biology studies have shown that ACE2 is also a functional receptor for the new SARS-CoV-2 coronavirus. After binding to ACE2 via its Spike protein, SARS-CoV-2 undergoes membrane fusion and enters the host cells by endocytosis. The ACE2 peptidase is a key regulator of the Renin-Angiotensin System (RAS). It is highly expressed in the heart, kidney, and testis, and is also expressed at lower levels in other tissues (mainly in the intestine and lungs) [14, 15] . Recent studies have shown that the binding of the S protein to ACE2 in the new coronavirus is 10 to 20 times stronger than in the SARS virus [16] , which may help the new coronavirus infect the host through the upper respiratory tract, significantly increasing its infectivity. Using TWIRLS, we were able to identify both ACE2 and DPP4 genes as CSHGs, and both were significantly associated with the C5 category. The HR label for this category is \"associated with S protein.\"In addition to ACE2 and DPP4, other CSHGs that are significantly associated with the C5 category include FURIN and TMPRSS2. The former may be required for the H7N1 and H5N1 influenza virus infections, probably via hemagglutinin-induced lysis, whereas the latter is widely reported to mediate and assist in the invasion of host cells by multiple viruses. Transmembrane protease serine 2 (TMPRSS2) is a serine protease that hydrolyzes and activates the spike glycoproteins of human coronavirus 229E (HCoV-229E), human coronavirus EMC (HCoV-EMC), Sendai virus (SeV) and human interstitial pneumovirus (HMPV), and 1,2,3 fusion glycoproteins of F0, 4a, and 4b human parainfluenza viruses (HPIV) [17, 18] . The function of this gene is essential for the transmission and pathogenesis of influenza A viruses (H1N1, H3N2 and H7N9 strains). It is also involved in the hydrolysis and activation of hemagglutinin proteins, which are essential for viral infectivity [19, 20] . Although entities in the C5 category and in the cited literature mainly show that virus invasion is facilitated by virus-binding receptors and membrane proteases, the biological mechanism of the receptor binding to viruses leading to pathological changes has been reported less frequently. All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.02.24.20025437 doi: medRxiv preprint TWIRLS recommend new genes that interact with C5 CSHGs, and other 1 o or 2 o CSGHs linked to this gene might be enriched in other categories. These inferences are based on a process that finds new genes connected to different categories. The connected categories suggested potential regulatory relationships between different biological functions or phenotypes. The genes that serve as linkers are potential targets for gain-and loss-of-function experiments to identify those systems described by the meaningful entities in these categories.In this paper, TWIRLS found the 2 o networks showed connections with certain CSHGs associated with categories or with no category. For example, TWIRLS found that CSHGs in the 2 o connections of IFITM1 were mainly concentrated in the C3 category (see Figure 4 ). Interestingly, CSHGs in the 2 o connections of ACE2 and DPP4 associated with C5 category were also enriched in C3 category, inferring that the information summarized in C3 category probably describe the underlying mechanisms of the pathological changes after coronavirus infection. In our analysis, the signaling pathways in C3 were mainly RAS, Vitamin D and RXR activation, and Chemokine signaling, with RAS being the most significant (as shown in Table 3 , which summarizes C3-related signaling pathways). which then linked to C3-associated cytokines including CCL5, CXCL1, CXCL10, CXCL11, CXCL2, CXCL9, CXCR2, and CXCR3 ( Figure 5 ). Subsequently, these linker genes may contain information on the biological mechanisms that may be important for understanding the disease.For example, TWIRLS recommended angiotensinogen (AGT) and angiotensin II receptor type 2 (AGTR2 or AT2R) genes in the C3 category associated with ACE2. This supports that RAS is probably involved in the pathological changes caused by cytokine storms after S protein binds to ACE2, as suggested by other reports.We next used TWIRLS to calculate the 1 o and 2 o networks of all 119 CSHGs. Based on the significantly enriched categories of CSHGs in the above networks, TWIRLS separately constructed models for the complex relationships of each CSHG. We found that 45.53% of the All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.02. 24.20025437 doi: medRxiv preprint CSHGs in these networks were associated with C3 or C10 categories, and five genes (CCL3, CCL5, CXCL1, CXCL2, and STAT2) were associated with both. This suggests that the biological mechanisms described by the C3 and C10 categories might be universally involved. Research on the entities, genes, pathways, and linker genes participating in the C3 and C10 categories could lead to new directions for the prevention, treatment, and clinical management of coronavirus infections.In this study, we used TWIRLS, a machine-based approach to collect, summarize, and analyze about 15,000 biomedical articles related to coronavirus, with the aim to elucidate the mechanisms underlying coronavirus-induced host pathological changes. Using TWIRLS, we found a possible mechanism involving ACE2/AT2R-RAS-Cytokine signaling, which becomes imbalanced under virus infection leading to cytokine storms. The TWIRLS system is an automated process that can summarize the entities and genes specifically related to coronaviruses. By combining this system with generalized interaction databases, we can reveal further associations that can provide a deeper understanding of the biological mechanisms of the disease phenotype caused by virus-host interactions.virus to ACE2 may disrupt this balance, which causes a steady-state imbalance of RAS, leading to subsequent pathological changes.Although Ang II was originally described as an effective vasoconstrictor, there is growing evidence that it is closely involved in the inflammatory response of the immune system.Pro-inflammatory cytokines derived from immune cells normally regulate the RAS component, which further accelerates the formation of systemic and local Ang II [28] [29] [30] . In particular, pro-inflammatory cytokines regulate the production of AGT in the liver and kidney [31] [32] [33] . On the other hand, RAS has also been implicated in mediating the cytokine storm and has functional relationships with the immune system. Angiotensin II regulates vascular tension and stimulates the release of pro-inflammatory cytokines [34, 35] . The production and release of CXC chemokines can induce the accumulation of neutrophils in vivo [36] . Meanwhile, ACE inhibitors and Ang II receptor blockers have been used in a number of cytokine-mediated inflammatory pathologies, and AT1R blockers (angiotensin receptor blocker) were shown to have beneficial effects that were commonly attributed to AT2R activation [37] . At the same time, it was reported that Ang II-stimulated human endothelial cells had increased release of a CXC chemokine, IP-10. The IFN-γ-inducible protein 10 (IP-10 or CXCL10) is mainly expressed in the lung and is a chemoattractant for activated T cells. The expression of IP-10 has been observed in many Th1-type inflammatory diseases, where it is thought to play an important role in recruiting activated T cells to sites of tissue inflammation. Therefore, RAS dysfunction may result in the accumulation of cytokines, such as in the lungs leading to excessive accumulation of immune cells and interstitial fluid, blocking the airways and causing eventual death. As reported in the first severely infected patients diagnosed with COVID-19, a large number of patients experienced \"cytokine storms\" that was fatal [7] . Figure 6 summarizes the functional changes and pathological consequences of RAS system after ACE2 combines with the coronavirus.We expect the mechanism summarized and reasoned by TWIRLS can be further supported by pathological evidence. To date, only one report of a post-mortem biopsy has been published with pathological data. Although histological examination showed bilateral diffuse alveolar damage with cellular fibromyxoid exudates, the right lung showed evidence of desquamation of All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.02.24.20025437 doi: medRxiv preprint pneumocytes and hyaline membrane formation, indicating acute respiratory distress syndrome (ARDS), whereas the left lung showed pulmonary edema with hyaline membrane formation, suggestive of early-phase ARDS. The pathological evidence suggests that ARDS symptoms are closely related to cytokine storm [38] . However, there is still a lack of histopathology-related data to support our preliminary findings generated by our machine approach.All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.02.24.20025437 doi: medRxiv preprintWe used PubMed, the most widely used database of biological literature, as the resource for the text mining. The schematic representation of the overall study design is shown in Figure 1 and can be summarized in the following steps.The dataset used in this pipeline were from PubMed articles. First, PubMed was searched for articles including titles, abstracts, author and affiliation information containing the subject keyword \"coronavirus\". The search results were downloaded in txt format for compiling into structured information. The text in the subject abstract set was organized and cleaned, and then assigned to specific corpuses related to coronavirus (specific corpus) and compiled into the subject dictionary. To enhance the accuracy of the effective entities associated with the keyword, we used a random corpus for comparisons. We searched for article abstracts containing the keyword \"public health\" and compiled the abstract set into a random corpus, and then compiled them into a randomized control dictionary, which contains a wide range of proteins, genes, and related biological entities. We also considered a balanced amount of information by setting relevant parameters to adjust the amount of text before carrying out the statistical analyses.Biological entity identification is a key step in the literature mining process [7, 8] . To ensure functionality of the extracted entity, we first compared the entity from the subject dictionary with the human official gene symbols in the Hugo Gene Nomenclature Commission (HGNC) database [9] to generate subject candidate genes using standard nomenclature. In addition, the entities in the abstract were capitalized to avoid errors in the identification process. To obtain widely used gene entities that are precisely related to the subject and to determine the significance of the gene distribution in the specific texts, we calculated the difference in the distribution proportions. We searched for the subject candidate genes in the subject dictionary and the randomized control dictionary, respectively. We also counted the number of abstracts containing each subject candidate gene in each abstract set, respectively. Finally, we calculated the odds ratio of each subject candidate gene and sorted them into a list of precisely related genes (CSHG).Similar to the process of identifying CSHG, we calculated whether entities were significantly distributed in a specific corpus. We counted the number of texts containing each CSHG in a specific corpus, and then counted the number of each candidate entity in the corpus subset. Next, we randomly selected the same amount of text from the random control corpus and then counted the number of each candidate entity in this subset of the random corpus. This was repeated 100-10000 times in the random corpus to generate candidate entities in the specified amount of text of the random distribution model. According to the central limit theorem (CLT), the distribution of random sampling averages of randomly distributed data always conforms to a normal distribution. Therefore, we can use the Z score to evaluate whether an entity is significant in a specific text. Here, we used a Z score cutoff value > 6.In addition, some entities have singular and plural noun forms, and synonyms with multiple forms in the abstracts. Therefore, we numbered the subject-related entity and automatically combined nouns with plural forms and homologous words with adjectives and adverb roots into the same entity, and then assigned them the same number. Figure 1 . the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.02.24.20025437 doi: medRxiv preprint CSHGs, the blue nodes represent genes that interact with CSHG in the string database (combination score> 800), and the red squares mark the most relevant entity category of CSHG.All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is . the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is . The yellow nodes represent the ACE2, DPP4 and IFITM1 genes, purple nodes represent genes that have 1 degree of interaction with the core genes, green circled purple nodes represent the genes connecting CSHG and C3 category-related genes, and pink nodes represent genes with 2 degrees of interaction with the core gene. The red diamonds show the most relevant entity category symbol for CSHG. All rights reserved. No reuse allowed without permission. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.02.24.20025437 doi: medRxiv preprint the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is . the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.02. 24.20025437 doi: medRxiv preprint the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.02. 24.20025437 doi: medRxiv preprint Tables   Table 1. Coronavirus-entity category labels and genes associated with each category. MISC indicates the label cannot be summarized. the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint (which was not peer-reviewed) is . https://doi.org/10.1101/2020.02.24.20025437 doi: medRxiv preprint ', \"The world is currently faced with a pandemic of novel coronavirus disease 2019 (COVID- 19) , which is caused by Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) and has no vaccine or cure. It is predicted the development of a safe and effective vaccine to prevent COVID-19 will take one year to 18 months, by which time it is likely that several hundreds of thousands to millions of people may have been infected. With a rapidly growing number of cases and deaths around the world, this emerging threat requires a nimble and targeted means of protection. Since coronaviruses causing COVID-19, Severe Acute Respiratory Syndrome (SARS), and Middle East Respiratory Syndrome (MERS) are able to suddenly transfer to humans from diverse animal hosts that act as viral reservoirs, there is a pressing need to develop methods to combat other potential coronaviruses that may emerge in the future [1] [2] [3] . A recent report further showed two strains (L and S) of SARS-CoV-2 with different genome sequences are circulating and likely evolving, further highlighting the need for a pan-coronavirus vaccination strategy 4 .The novel coronavirus causing COVID-19 belongs to a family of positive-sense RNA viruses, which typically infect the upper and lower respiratory tracks and cause disease by direct cytotoxic effects and the induction of host cytokines disease 5 . The SARS-CoV-2 life cycle is likely similar to closely related coronaviruses such as the virus that causes SARS, in which the virus enters the cell, releases its RNA genome into the cytoplasm, and synthesizes negativesense genomic and subgenomic RNAs from which viral mRNAs and a new copy of the positive sense viral genome are synthesized (Fig. 1A) 6, 7 . Whereas traditional vaccines work by priming the human immune system to recognize viral proteins or weakened viruses and decrease viral entry into cells 8 , the alternative antiviral approach we propose here relies on a CRISPR-based system for recognizing and degrading the intracellular viral genome and its resulting viral mRNAs (Fig. 1B) . Targeting the positive-sense genome and viral mRNAs to simultaneously degrade viral genome templates for replication and viral gene expression would be expected to robustly limit viral replication.To inhibit RNA viruses in human cells, we used the CRISPR-Cas13d system derived from Ruminococcus flavefaciens XPD3002, a recently discovered RNA-guided RNA endonuclease 9, 10 . Cas13d employs CRISPR-associated RNAs (crRNAs) that contain a customizable 22 nucleotide (nt) spacer sequence that can direct the Cas13d protein to specific RNA molecules for targeted RNA degradation. The high catalytic activity of Cas13d in mammalian cells provides a potential mechanism for targeting SARS-CoV-2 for specific viral RNA genome degradation and viral gene expression inhibition. Because of its small size (967 amino acids), high specificity, and strong catalytic activity, we chose Cas13d rather than other Cas13 proteins to target and destroy RNA viruses including SARS-CoV-2 and Influenza A virus (IAV) [10] [11] [12] .In this work, we developed a Prophylactic Antiviral CRISPR in huMAN cells (PAC-MAN) strategy as a form of genetic intervention to target SARS-CoV-2, IAV, and potentially all sequenced coronaviruses. We created a bioinformatic pipeline to define conserved regions across the SARS-CoV-2 genomes and target these regions using CRISPR-Cas13d for viral genome degradation and viral gene inhibition. At the time of paper submission, there is no widely available laboratory strains of SARS-CoV-2. Therefore, we tested our approach using synthesized fragments of SARS-CoV-2, as well as with live H1N1 IAV. We designed and screened a panel of crRNA pools targeting conserved viral regions and defined the most effective crRNAs. We demonstrated the ability of our approach to cleave SARS-CoV-2 fragments and to reduce the replication of IAV in human lung epithelial cells. Our bioinformatics author/funder. All rights reserved. No reuse allowed without permission.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.13.991307 doi: bioRxiv preprint Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza Abbott et al. Manuscript analysis revealed a group of six crRNAs that can target 91% of sequenced coronaviruses, as well as a group of 22 crRNAs able to target all sequenced coronaviruses. The potential pancoronavirus protection using CRISPR-Cas13d offers an alternative and complementary approach over traditional pharmaceuticals or vaccines. Through the use of crRNA pools targeting different regions of the same virus or different strains of coronavirus, this system could possibly buffer against viral evolution and escape, as well as enable rapid development and deployment against emerging viruses. When combined with an effective delivery platform, PAC-MAN is a promising strategy to combat not only coronaviruses including that causing COVID-19, but also a broad range of other genera of viruses. author/funder. All rights reserved. No reuse allowed without permission.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.13.991307 doi: bioRxiv preprint Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza Abbott et al. ManuscriptTo create effective and specific crRNA sequences to target and cleave SARS-CoV-2, we first performed a bioinformatic analysis by aligning published SARS-CoV-2 genomes from 47 patients with SARS-CoV and MERS-CoV genomes at the single-nucleotide resolution level. SARS-CoV-2 has a single-stranded RNA genome with ~30,000 nucleotides that encodes 12 putative, functional open reading frames [13] [14] [15] . Our analysis found regions with a high conservation between 47 SARS-CoV-2, SARS-CoV and MERS-CoV genomes ( Fig. 2A) . The two highly-conserved regions respectively contain the RNA-dependent RNA polymerase (RdRP) gene in the polypeptide ORF1ab region, which maintains the proliferation of all coronaviruses, and the Nucleocapsid (N) gene at the 3' end of the genome, which encodes the capsid protein for viral packaging.author/funder. All rights reserved. No reuse allowed without permission.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.13.991307 doi: bioRxiv preprint Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza Abbott et al. ManuscriptTo target highly conserved SARS-CoV-2 regions, we generated an in silico collection of all 3,802 possible crRNAs (Supplemental Fig. 1 ). After excluding crRNAs either predicted to have potential off-target binding (≤1 mismatch) in the human transcriptome or having poly-T (≥4 Ts) sequences that may prevent crRNA expression, we obtained a collection of 3,203 crRNAs (Supplemental Table 1 ). We designed and synthesized 40 crRNAs, with 20 crRNAs each targeting the conserved sequences of the RdRP and N genes (Supplemental Table 2 ). Our rationale for densely targeting these two regions was to significantly reduce both viral genomic RNA and mRNA templates for expressing essential viral proteins and to minimize the risk of loss of targeting activity by mutational escape.To evaluate whether Cas13d is effective for targeting SARS-CoV-2 sequences, we created two reporters expressing synthesized fragments of SARS-CoV-2 fused to GFP (SARS-CoV-2-F1 and SARS-CoV-2-F2; Fig. 2B , Supplemental Table 3 ). As SARS-CoV-2 appears to mainly infect respiratory tract cells in patients 5 , we chose to use human lung epithelial A549 cells as a model cell line. We created a stable A549 cell line expressing Cas13d through lentiviral infection, followed by sorting for the mCherry marker that was co-expressed with Cas13d ( Fig.  2C) .We first investigated which regions of the SARS-CoV-2 fragments were most susceptible to Cas13d-mediated targeting and cleavage. To do this, we transfected or transduced the SARS-CoV-2 reporters into Cas13d A549 cells that had been transduced with pools of four crRNAs targeting either RdRP or N gene regions (Fig. 2D , see Methods). We chose to evaluate the effectiveness of our system using a pool of crRNAs, since in the context of live viral infection, this would prevent the possibility of escape from inhibition due to a mutation involving a single crRNA target site. A total of ten groups (G1-G10) were tested for all 40 crRNAs (Supplemental Table 2 ). Twenty-four hours after SARS-CoV-2 reporter transfection, we performed flow cytometry to examine levels of GFP protein expression and collected RNA from cells to perform quantitative real-time PCR (qRT-PCR) to examine mRNA transcript abundance.We observed that most RdRP-targeting crRNA pools were able to repress reporter expression to some extent compared to the control, and one pool targeting the middle of the SARS-CoV-2- Table 2 for the designed crRNA sequences and Supplemental Table 3 author/funder. All rights reserved. No reuse allowed without permission.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.13.991307 doi: bioRxiv preprint Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza Abbott et al. Manuscript F1 RdRP region (G4; SARS-CoV-2 genome coordinates 13,784-14,149) was able to repress GFP by 86% (p = 2x10 -6 ) (Fig. 3A, S2A -B, Supplemental Table 4 ). One pool of N genetargeting crRNAs (G8; SARS-CoV-2 genome coordinates 28,803-29,034) was able to substantially repress SARS-CoV-2-F2 GFP, causing a 71% decrease in expression (p = 2x10 -7 ) (Fig. 3B, S2A -B, Supplemental Table S4 ). Our qRT-PCR analysis showed consistent results at the RNA level, with G4 and G8 inhibiting their respective reporter mRNA abundance by 83% (p = 3x10 -11 ) and 79% (p = 2x10 -12 ) ( Fig. 3A -B, Supplemental Table S4 ). The variations in the ability of different crRNA pools to repress the SARS-CoV-2 reporters are likely due to RNA secondary structure inherent in the SARS-CoV-2 genome or differences in binding affinities for each crRNA sequence composition. Table 4 . P values for C-E are labeled for each group.author/funder. All rights reserved. No reuse allowed without permission.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.13.991307 doi: bioRxiv preprint Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza Abbott et al. ManuscriptWe next independently validated the performance of adjacent crRNA pools when SARS-CoV-2-F1 or -F2 was introduced via lentiviral transduction. We argue that this approach, in which the lentivirus-derived RNA serves as a PAC-MAN target prior to lentivirus integration into DNA, mimics the crRNA targeting conditions that would apply for natural COVID-19 infection. We tested on a few selected crRNA pools, including the 3 best groups G4, G5, and G8 and one less efficient group G1, with a lentiviral multiplicity of infection (MOI) of 0.5. Our results revealed similar patterns to our SARS-CoV-2 transfection experiments, with the best groups (G4, G5, G8) able to repress their reporters by 69%, 71%, and 60% (p = 7x10 -6 , 10 -3 , 3x10 -6 for G4, G5, G8, respectively) (Fig. 3C) . qRT-PCR analysis also showed consistent results, with G4, G5, and G8 repressing 70%, 68%, and 49% of RNA abundance (p = 8x10 -8 , 4x10 -6 , 10 -4 for G4, G5, G8 respectively) (Fig. 3D) .We further validated the effectiveness of Cas13d-mediated repression of SARS-CoV-2 reporters by co-transfecting each reporter with a pool of 5 crRNAs tiled along the whole fragment, compared to a pool of 5 non-targeting control crRNAs (Table S2) . We found that the RdRPtargeting crRNAs were able to repress SARS-CoV-2-F1 GFP by 81% (p = 0.01), while Ntargeting crRNAs were able to repress SARS-CoV-2-F2 GFP by 90% (p = 5x10 -4 ) (Fig. 3E,  S3A) . We also did an analysis of the extent to which expression of Cas13d or crRNAs affected SARS-CoV-2 GFP reporter inhibition. Our analysis revealed that SARS-CoV-2 inhibition was more sensitive to crRNA concentration in our samples, while lower Cas13d expression only moderately decreased inhibitory activity (Fig. S3B) . Thus, maintaining a high level of crRNA concentration is likely a determining factor for more effective SARS-CoV-2 sequence targeting and cleavage.These data together suggest: 1) Cas13d PAC-MAN can be an effective system to target and degrade SARS-CoV-2 sequences in human cells and 2) proper design of crRNAs are important for obtaining a high efficiency of SARS-CoV-2 inhibition.Since we do not yet have access to live SARS-CoV-2 virus, as a proof-of-concept we elected to test the CRISPR-Cas13d strategy on inhibiting H1N1 IAV, a RNA virus with a similar tropism as SARS-CoV-2 for respiratory tract epithelial cells. In contrast to SARS-CoV-2, which has only a single, continuous RNA genome, the IAV genome is contained in 8 negative-sense RNA segments, in which each plays an important role in packaging the viral RNA into budding virions 16, 17 .To create crRNAs targeting a broad range of IAV strains, we aligned all complete IAV genomes retrieved from the Influenza Research Database and searched for the most conserved regions (Supplemental Table 5 ). Our analysis and the work of others showed that the segment ends are highly conserved for all 8 segments [16] [17] [18] [19] [20] [21] . The segment ends are potentially attractive regions for targeting with Cas13d because of the potential to inhibit a broad range of IAV strains and because of the previous evidence that interfering with the packaging of one segment encoded on the segment ends can decrease the packaging efficiency of other segments and overall virion packaging 18, [22] [23] [24] [25] . Using sequence representation from ~140 different strains of influenza, we designed crRNAs that could be robust across as many different IAV strains as possible. Our bioinformatics analysis resulted in 6 crRNAs targeting highly conserved genome regions for each of the 8 IAV segments, for a total of 48 crRNAs (Supplemental Table 6 ).author/funder. All rights reserved. No reuse allowed without permission.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.13.991307 doi: bioRxiv preprint Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza Abbott et al. ManuscriptTo test the efficiency of IAV-targeting crRNAs, we performed a screen of our crRNA pools in the stable Cas13d A549 cell line to determine which were most effective at inhibiting IAV infection (Fig. 4A) . To do this, we transfected a pool of 6 crRNAs targeting a given IAV genome segment. Two days after crRNA transfection, the Cas13d A549 cells were challenged with PR8-mNeon, a strain of H1N1 IAV (A/Puerto Rico/8/1934) engineered to express the mNeonGreen gene, a fluorescent reporter protein (hereafter referred to as PR8-mNeon) at an MOI of 2.5 or 5.0 [26] [27] [28] . At approximately 18 hours post-challenge, the cells were analyzed for IAV infection through flow cytometry and microscopy. We examined the percentage of cells that were mNeon positive for each segment-targeting crRNA pool and calculated the fold-change compared to cells transfected with a pool of non-targeting crRNAs). Out of all crRNAs, the crRNA pool targeting segment 6 (S6) delivered the most consistent and robust results across different MOIs (72% reduction for MOI = 2.5 and 52% reduction for MOI = 5; Fig. 4B, S4) . Additionally, the segment 4 (S4) pool also showed moderate but consistent inhibition. To verify Cas13d-mediated inhibitory effects on S4 and S6, we further tested at a lower MOI of 0.5, which showed better inhibition of IAV across samples (e.g., 79% reduction using crRNAs targeting S6; Fig. S5 ). This confirms consistent inhibitory activity of IAV by Cas13d when targeting these two segments. There is a possible trend of greater inhibition at lower viral titers, suggesting that Cas13d PAC-MAN could be a particularly effective strategy for prevention of new infections, which typically occurs from exposure to a low level of virus.We further characterized the S6-targeting crRNA pool. S6 encodes the gene neuraminidase (NA), which releases budding virions from the host cell 16 . We performed microscopy quantification of mNeon+ cells and found that mNeon expression was reduced by 62% (p = 10 -5 ) and 73% (p = 5x10 -9 ) with an MOI of 2.5 and 5, respectively, with S6-targeting crRNAs (Fig. 4C) and this trend was corroborated by flow cytometry (Fig. 4D) . Together, our data show that Cas13d PAC-MAN is able to target highly conserved viral regions and robustly inhibit viral replication in human lung epithelial cells.In the past two decades, multiple variants of coronavirus, including those causing COVID-19, SARS and MERS, emerged from animal reservoirs and infected humans, each time causing significant disease and fatalities 1-3 . Thus, the design of a strategy that could broadly prevent and target viral threats, including all coronavirus strains that currently reside in animals, would be a valuable resource. We asked whether it is possible to design a minimal number of crRNAs that could target a majority of known coronaviruses found in both humans and animals.To do this, we analyzed all known coronavirus genomes (3,051) to identify all possible crRNAs that can target each of those genomes, ending up with approximately 6.48 million possible crRNAs (Fig. 5A, S6) . We then refined our list to define the smallest number of crRNAs that could target all known coronavirus genomes with zero mismatches. We found that just two crRNAs could target ~50% of coronavirus genomes, including those causing COVID-19, SARS, and MERS; 6 crRNAs were able to target ~91% of coronavirus genomes; and 22 crRNAs covered all sequenced coronaviruses with no mismatches (Fig. 5B, Supplemental Table 7 ). The ability to use a relatively small number of crRNAs to broadly target most or all coronavirus strains further highlights the uniqueness of our approach in contrast to traditional pharmaceutical or vaccination approaches.As a resource, we provide a map to show how our top 6 crRNAs (PAC-MAN-T6) targeted the coronavirus phylogenetic tree (Fig. 5A, red box) . Beta coronaviruses, the genus of viruses causing COVID-19, SARS, and MERS, were mostly covered by 3 crRNAs (crRNA 1-3) , while the other genera were covered by these three plus the remaining 3 crRNAs. Altogether, the PAC-MAN-T6 can target all known human coronavirus with broad coverage against other animal coronaviruses.The minimal set of six crRNAs also included one crRNA (designated crRNA-N18f) that we validated. A recent work analyzed 103 SARS-CoV-2 genomes and indicated that there are two major types (L and S) of SARS-CoV-2 existing with different viral signature sequences 4 . To verify whether crRNA-N18f can target all L and S strains, we retrieved a set of 202 recently sequenced SARS-CoV-2 sequences from Global Initiative on Sharing All Influenza Data author/funder. All rights reserved. No reuse allowed without permission.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.13.991307 doi: bioRxiv preprint Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza Abbott et al. Manuscript(GISAID). Notably, crRNA-N18f targets all 201 genomes, with only one SARS-CoV-2 sequence carrying a single mismatch mutation (Supplemental Table 8 ). This suggests that our approach can robustly target multiple SARS-CoV-2 strains, but also suggests the potential need to use a pool of crRNAs to avoid mutational escapes. author/funder. All rights reserved. No reuse allowed without permission.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.13.991307 doi: bioRxiv preprint Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza Abbott et al. ManuscriptCRISPR-Cas13 emerged as a natural bacterial defense against bacteriophages, a powerful antiviral system that is able to use sequence-specific crRNAs to protect host bacterial cells from infections 29 . Here, we have repurposed the RNA-guided RNA endonuclease activity of Cas13d in mammalian cells against emergent viral targets, SARS-CoV-2 and IAV, in our PAC-MAN strategy. This expands the applications of CRISPR-Cas13 systems in addition to their uses for diagnostics such as SHERLOCK and live-cell imaging [30] [31] [32] [33] . Prior work showed Cas13a/b systems could inhibit ssRNA viruses including influenza, which is consistent with our observed high efficiency of SARS-CoV-2 reporter and IAV inhibition using the PAC-MAN approach 31 . We demonstrated that Cas13d-based genetic targeting can effectively target and cleave the RNA sequences of SARS-CoV-2 fragments and IAV in lung epithelial cell cultures. Our bioinformatics analysis also suggested a minimal pool of 6 crRNAs able to target over 90% of sequenced coronaviruses. While this strategy is a proof-of-concept and will require further testing using replication-competent SARS-CoV-2 viruses and validation in animal models before clinical tests in humans, it represents a unique approach to implement a rapid and broad antiviral defense in humans against emerging pathogens for which there are no effective vaccines.For both SARS-CoV-2 and IAV, we found highly conserved regions of the viral genomes to target with Cas13d. In the case of SARS-CoV-2, these genome regions encode the RdRP and Nucleocapsid proteins, which are essential for coronavirus replication and function 13, 34 . RdRP is responsible for catalyzing the replication of all viral mRNAs and Nucleocapsid binds to genomic RNA, protecting it and serving as one of the two main structural proteins in virions. Targeted inhibition of these proteins could have an outsized effect on disabling virus production and function, in addition to reducing viral load through degradation of the viral genome itself. For IAV, the crRNAs that showed the best viral inhibition target the conserved ends of the segment S6 that encodes Neuraminidase (NA), a viral surface protein essential for mediating budding of new virions 35 . Prior mutation analysis has shown that mutating the packaging signals of one segment end leads to decreased packaging of other segments, indicating that there is a cooperative mechanism for packaging the IAV genome 18 . Thus, by inhibiting a single IAV genome segment, we could reduce the overall packaging of IAV in a synergistic fashion.Notably, the SARS-CoV-2 RdRP gene and IAV NA gene that we targeted in our study are also the targets of two antiviral drugs, Remdesivir and Oseltamivir. Remdesivir, created by Gilead Sciences (development code GS-5734), is an RdRP inhibitor that was developed to treat Ebola and Marburg virus infections and has been reported to have antiviral activity against MERS and SARS 36-38 . Remdesivir is already administered for COVID-19 through compassionate use requests, and clinical trials for its use against COVID-19 have already started in the U.S.(clinical trial ID NCT04280705) and China. Oseltamivir (also known as Tamiflu), is an antiviral medication for treating and preventing IAV that acts as an inhibitor of NA, thereby preventing the egress of new viral particles 39 . It will be interesting to see if these drugs could be used in combination with Cas13d PAC-MAN to synergistically cripple viral function and replication.While we demonstrate that the PAC-MAN system is able to exhibit strong repression of viral sequences in an in vitro setting, it must be coupled with an effective in vivo delivery system for therapeutic use. There are several potential strategies that could be employed for transient in vivo expression of CRISPR components. Cas13d and its cognate crRNAs could be delivered as RNAs within polymers or lipid nanoparticles, perhaps with chemical alterations to increase stability 40 . In addition, a DNA-based liposomal delivery strategy, such as the recently developed HEDGES platform is also attractive 41 . Yet another strategy would be to deliver a author/funder. All rights reserved. No reuse allowed without permission.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.13.991307 doi: bioRxiv preprint Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza Abbott et al. Manuscript 13 ribonucleoprotein complex containing purified Cas13d assembled with crRNAs 42, 43 . All of these could potentially be used both as a therapeutic and as a prophylactic measure.If the delivery barriers are overcome and a strategy like this is able to be used therapeutically, there are many potential benefits over traditional vaccines. Traditional vaccines rely on priming the immune system through exposure to viral proteins or peptides often derived from surface proteins that exhibit a high rate of mutation, which increased the chances of viral evasion of the host immune response 44 . In contrast, here we have demonstrated a genetic strategy that is able to target highly conserved regions, which would be expected to make it much more unlikely for the virus to escape inhibition through mutation. In addition, the ability of Cas13d to process its own crRNAs from a crRNA array means that multiple crRNAs targeting different regions (e.g. Fig. 3E , and PAC-MAN-T6 in Fig. 5A ) could be delivered simultaneously 9 , further reducing the chances of viral escape. As a further advantage, we demonstrate a potential pan-coronavirus strategy to target not only viruses that circulate in humans, but also those that currently are found in animal reservoirs that might transfer to humans to cause disease. If the crRNAs targeting these viruses can be tested and validated before they ever infect humans, we can greatly accelerate the development of countermeasures for future emergent threats.In summary, our PAC-MAN strategy represents a potentially powerful new approach for inhibiting viral function and replication, and we envision it could be useful for a diverse array of circulating and emergent viral threats.47 complete SARS-CoV-2 assemblies were downloaded from (https://www.ncbi.nlm.nih.gov/genbank/2019-ncov-seqs/) on February 21, 2020. All the other 3,108 Coronavirinae complete genome sequences were downloaded from ViPR (Virus Pathogen Resource) database on February 21, 2020. After excluding very short genomes, we collected in total 3,051 Coronavirinae virus genomes. 202 SARS-CoV-2 genome sequences were downloaded from GISAID (Global Initiative on Sharing All Influenza Data; https://www.gisaid.org/).We developed a full computational workflow to design crRNAs for the Cas13d system. To design all possible crRNAs for the three pathogenic RNA viruses (SARS-CoV-2, SARS-CoV, and MERS-CoV), the reference genomes of SARS-CoV, MERS-CoV, along with SARS-CoV-2 genomes derived from 47 patients were first aligned by MAFFT using the --auto flag. crRNA candidates were identified by using a sliding window to extract all 22 nt sequences with perfect identity among the SARS-CoV-2 genomes. We annotated each crRNA candidate with the number of mismatches relative to the SARS-CoV and MERS-CoV genomes, as well as the GC content. 3,802 crRNA candidates were selected with perfect match against the 47 SARS-CoV-2 genomes and with ≤1 mismatch to SARS-CoV or MERS-CoV sequences. To characterize the specificity of 22nt crRNAs, we ensured that crRNA do not target any sequences in the human transcriptome. We used Bowtie 1.2.2 to align crRNAs to the human transcriptome (HG38; including non-coding RNA) and removed crRNAs that mapped to the human transcriptome with fewer than 2 mismatches.We maximized the vertical coverage of pooled crRNAs to target a maximal set of the 3,051 Coronavirinae viruses with a minimal set of crRNAs. A sliding window was used to extract all unique 22 nt sequences in the Coronavirinae genomes, yielding 6,480,955 unique crRNA candidates. A hash table was used to map each crRNA candidate to the number of Coronavirinae genomes that it targets with a perfect match. A greedy algorithm was used to identify a minimal set of covering crRNAs. In each iteration, the crRNAs were sorted in descending order by the number of genomes targeted. The crRNA that targeted the most genomes was added to the minimal set of crRNAs, and all of the genomes it targeted were removed from the hash table values. If multiple crRNAs were tied for targeting the most genomes, the crRNAs were ranked by the length and quantity of stretches of repeated nucleotides, and the lowest ranking crRNA (i.e. the one with the fewest, shortest stretches of repeated nucleotides) was added to the set of minimal crRNAs. Using this approach, a set of 22 crRNAs was identified that was able to target all 3150 Coronavirinae virus genomes (including 47 SARS-CoV-2). The phylogenetic tree and the associated annotations were generated by the Interactive Tree Of Life (iTOL v5.5; https://itol.embl.de/).All the complete SARS-CoV-2 genome sequences were aligned with the SARS-CoV and MERS-CoV NCBI Refseq sequences by MAFFT using the --auto flag. The alignment was visualized using the Geneious Prime software (Geneious 2020.0.4; https://www.geneious.com).author/funder. All rights reserved. No reuse allowed without permission.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.13.991307 doi: bioRxiv preprint Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza Abbott et al. ManuscriptA consensus nucleotide (which is shared by >50% of non-gap characters at the given position) was assigned to each position in the alignment. Not every position has a consensus nucleotide.The percent conservation at each position was calculated as the percentage of sequences matching the consensus at that position. To aid interpretation, the resulting plot of percentage conservation was smoothed using a moving average with a window size of 1,001 bp centered at each position. Positions corresponding to gap characters in the SARS-CoV-2 reference sequence were omitted.The crRNA plasmids were cloned using standard restriction-ligation cloning. Forward and reverse oligos for each spacer (IDT) were annealed and inserted into backbone using T4 DNA Ligase (NEB). Assembled oligos were either inserted into a pHR or pUC19 backbone, obtained and modified from Addgene (#121514 and #109054, respectively). Spacer sequences for all crRNAs can be found in Supplemental Table 2 and 6.To clone SARS-CoV-2 reporters, pHR-PGK-scFv GCN4-sfGFP (pSLQ1711) was digested with EcoR1 and Sbf1 and gel purified. The PGK promoter and sfGFP were PCR amplified from pSLQ1711 and gel purified. The SARS-CoV-2-F1 and SARS-CoV-2-F2 fragments were synthesize from Integrated DNA Technologies (IDT). At last, the PGK, sfGFP, and SARS-CoV-2-F1/F2 fragments were inserted into the linearized pSLQ1711 vector using In-Fusion cloning (Takara Bio).On day 1, one confluent 100mm dish (Corning) of HEK293T cells were seeded into three 150mm dishes (Corning). On day 2, cells were ~50-70% confluent at the time of transfection. For A549 cells, lentivirus precipitation solution (Alstem) was added and precipitated as per the manufacturer's protocol. One well of a 6-well plate (Corning) of A549 cells at ~50% confluency were transduced with the precipitated lentivirus. After 2-3 days of growth, the cell supernatant containing virus was removed and the cells were expanded. Cells were then sorted for mCherry+ cells using a Sony SH800S cell sorter. Table S2 ). On day 3, cells were switched to fresh medium with Puromycin at 2 ug/mL. Twenty-four hours after Puromycin selection, cells with transfected crRNAs were challenged with SARS-CoV-2 reporter plasmids or SARS-CoV-2 reporter lentivirus. Twenty-four hours after transfection or 48 hours after transduction, cells were tested using flow cytometry on a Beckman-Coulter CytoFLEX S and qRT-PCR on a Biorad author/funder. All rights reserved. No reuse allowed without permission. The PR8 mNeon IAV was generated by insertion of the mNeon fluorescent gene into segment 4 of the H1N1 A/Puerto Rico/8/1934 strain (Nicholas Heaton's Lab, Duke University) as previously described . The PR8-mNeon virus was propagated in chicken eggs, and harvested allantoic fluid containing the virus was titered using MDCK plaque assays, and frozen in aliquots for later use.3.1x10 6 Cas13d A549 cells were plated in two 100 mm dishes. The following day, the cells were transfected with 15 μg pooled crRNAs targeting the IAV genome or non-targeting controls (Supplemental Table 6 ) in 1.5 mL Opti-MEM reduced serum media and 30 μL Mirus LT1 reagent. After approximately 24 hours, the transfected Cas13d A549 cells were dissociated and re-plated in 24-well plates at a density of 15-20,000 cells/well and incubated overnight. Flow cytometry was performed on excess cells to quantify the transfection efficiency. Cells were challenged overnight with mNeonGreen expressing H1N1 A/Puerto Rico/8/1934 at an MOI of 2.5 and 5. Uninfected cells were included as a negative control. An independent two-tailed T test was used to calculate the p values and statistics in Fig. 4C-D. author/funder. All rights reserved. No reuse allowed without permission.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.13.991307 doi: bioRxiv preprint Development of CRISPR as a prophylactic strategy to combat novel coronavirus and influenza Abbott et al. ManuscriptReal-time qRT-PCR was performed to quantify RNA abundance. For each sample, total RNA was isolated by using the RNeasy Plus Mini Kit (Qiagen Cat# 74134), followed by cDNA synthesis using the iScript cDNA Synthesis Kit (BioRad, Cat# 1708890). qRT-PCR primers were ordered from Integrated DNA Technologies (IDT). Quantitative PCR was performed using the PrimePCR assay with the SYBR Green Master Mix (BioRad), and run on a Biorad CFX384 realtime system (C1000 Touch Thermal Cycler), according to manufacturers' instructions. Cq values were used to quantify RNA abundance. The relative abundance of the SARS-CoV-2 fragments was normalized to a GAPDH internal control.Microscopy for SARS-CoV-2 experiments was performed on a Nikon TiE inverted confocal microscope equipped with an Andor iXon Ultra-897 EM-CCD camera and 405 nm, 488 nm, 561 nm and 642 nm lasers, using the 20x PLAN APO air objective (NA = 0.75). Image were taken using NIS Elements version 4.60 software. Microscopy for IAV experiments was performed on a Keyence BZ-X810 microscope equipped with a GFP and Texas Red filter was used to obtain images with a 20X objective lens.A549 cells that express Cas13d and are transfected with crRNAs and challenged with PR8 mNeon virus were washed with 1X PBS, treated with 1X Trypsin EDTA and fixed in 1.6% paraformaldehyde in PBS for 10 minutes. Cells were washed with FACS buffer (1X PBS, 0.3% BSA, 1mM EDTA). BD Accuri C6 plus flow cytometer was used to collect raw data. Raw data were processed with Cytobank (BD) software.author/funder. All rights reserved. No reuse allowed without permission.The copyright holder for this preprint (which was not peer-reviewed) is the . https://doi.org/10.1101/2020.03.13.991307 doi: bioRxiv preprint\", 'An outbreak of a novel coronavirus, recently renamed CoVID-19, was first reported from Wuhan, China on 31 December 2019. During January 2020, the outbreak spread to multiple cities in China, and the first cases started appearing outside China. By the end of January 2020, 9,720 cases had been confirmed in China, with 106 confirmed cases outside China across 19 different countries (1) .Epidemiological analysis of the outbreak was quickly used to start estimating epidemiologicallyrelevant parameters, such as the basic reproduction number, the serial interval, the incubation period and the case fatality rate (2) (3) (4) (5) (6) (7) . Initial estimates suggested that the reproduction number was between 2 and 3 and the case fatality rate was less than 4% (8) . Control of spread by contact tracing and isolation appears to be challenging, given what is currently known about the virus (9) .Mathematical models are useful tools for understanding and predicting the possible course of an outbreak, given a set of underlying assumptions. Here, we adapt a metapopulation model of disease transmission in England and Wales to capture the spread of CoVID-19 (10) . The aim is to provide predictions about the likely timing of the peak of the epidemic in England and Wales and spatial features of spread.We use an existing national-scale stochastic metapopulation model of disease transmission in England and Wales. The model structure is based on the metapopulation model described in detail in Danon et al (2009) (10) . In this model, the population is divided into electoral wards. Because of the changes in data availability, we restricted the model to England and Wales, whereas the original model covered Great Britain.Transmission between wards occurs via the daily movement of individuals. For each ward, we assume that individuals contribute to the force of infection in their \"home\" ward during the night and their \"work\" ward during the day. See Danon et al 2009 for further details (10) .Data for population and movement of individuals come from the 2011 census of the United Kingdom. The population size of each of the 8,570 electoral wards is available directly from the Office of National Statistics (ONS) website. The number of individuals moving between locations is also available from the ONS website, but at the level of census output areas (OAs). We aggregated the data from OA level to electoral wards level. Spatial location of electoral ward centres are extracted from maps available from the ONS websites.We use a Susceptible-Exposed-Infectious-Infectious-Recovered (SEIIR) model within each ward to capture the progression of disease within an individual (figure 1). Initial analyses used SARS-like parameters for the incubation period and infectious period, which now appear to differ from CoVID-19(4). Li et al (2020) analysed data on 425 cases reported in Wuhan in China and fitted a log-normal distribution to the incubation period, and a gamma distribution for the serial interval (2) . The infectious period for SARS was estimated as the serial interval minus the . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20022566 doi: medRxiv preprint incubation period, but as Li et al did not report the correlation between incubation period and serial interval, we were not able to estimate the infectious period distribution from the data, but used a uniform distribution between 2 and 3 days, to give a mean serial interval of approximately 7-8, in line with current estimates. We used two infectious states to represent a mildly symptomatic or prodromal period and a period with more pronounced symptoms. In the absence of data on the relative magnitude of these two infections states, we assumed the same length of time in each infectious state and assumed that each state was equally infectious. We sampled from each of the distributions 100 times independently (Table 1 ). The census data are used to initialise the population sizes within each of the 8,570 wards. At the start of the model, all individuals are assumed to be susceptible to infection with no 3 e . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20022566 doi: medRxiv preprint underlying immunity in the population. We investigated a range of starting scenarios by seeding the infection in example wards London, Birmingham, Brighton, Sheffield and Cardiff. To seed infection in a ward, we move five individuals (non-commuters) from the susceptible compartment to the first infectious state.We investigated the impact of a seasonally affected transmission rate, to capture potential decreased transmission during the summer months. We captured seasonal transmission by replacing the constant transmission rate with a time-varying transmission rate given by:is the magnitude of the seasonal difference in transmission, ranging from(maximum seasonality with no transmission at the peak of the summer).From the model, we extracted the total number of infections per day, as the number of individuals in both of the Infectious states, and the number of infected wards per day as the total number of wards with at least one individual in one of the two Infectious states. The spatial growth of the epidemic in England and Wales was visualised using interactive maps. We estimated the timing of the epidemic peak from the aggregated epidemic curve and calculated 95% prediction intervals from the model simulations.The model is coded in C and is available on github (http://github.com/ldanon/MetaWards). The data are freely available from the Office for National Statistics website, or can be downloaded with the code at the github repository.We predict that, in the absence of any interventions, a disease with \"best-guess\" CoVID-19-like parameters will peak a median of 133 days (range 126 -147 days) following the start of personto-person transmission in England and Wales. Intrinsic model stochasticity is responsible for variation between model runs. Using exactly the same parameters and seeding the infection in the same initial wards resulted in a difference in peak timing of +/-10 days (figure 2). The attack rate for best-guess parameters had a median of 45799874 (81.67% range 81.64-81.69), with a peak incidence median 1,116,692.. CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20022566 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20022566 doi: medRxiv preprintThe initial location of cases had some, but limited impact on the timing of the epidemic in England and Wales. Epidemics seeded in Brighton, London, Birmingham and Sheffield resulted in synchronised epidemics in England, reaching urban areas first followed by rural areas. Epidemics started in Cardiff had a slower time to peak but still resulted in a generalised outbreak.Spatially, some disaggregation between England and Wales regions is observed. An outbreak starting in Brighton, (South East England) peaks in London and the South East first, and North East England, Yorkshire and Humber and Wales last, with a ten-day lag between regions ( Figure 3 ).Model predictions are highly sensitive to parameter values and incorporating parameter uncertainty increases the variability of model predictions. In the absence of any control measures, all predictions resulted in epidemics that peaked within a year from the start of person-to-person transmission in England and Wales. Estimates of peak time ranged from 78 days to 241 days (Figure 4 ).. CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20022566 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20022566 doi: medRxiv preprint However, seasonality in transmission has a large impact on epidemic timing, peak incidence, and final attack rates. Assuming no difference in transmission rate during the year leads to a single large epidemic after approximately 4 months (June time if transmission starts in February), as above. With a 25% reduction in transmission the epidemic is smaller and peaks later, reducing the overall attack rate by 20%. A 50% reduction in transmission results in a smaller epidemic before the summer, followed by a resurgence in cases in the following winter. The attack rate is 10% less than a non-seasonal epidemic. A 75% reduction in transmission over the summer resulted in a delayed large outbreak, but with a similar attack rate. If transmission decreases to zero over the summer then the resulting outbreak is much reduced, with an attack rate of less than 1% ( Figure 5 , Table 2 ). . CC-BY-NC-ND 4.0 International license It is made available under a author/funder, who has granted medRxiv a license to display the preprint in perpetuity.is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.02.12.20022566 doi: medRxiv preprint Table 2 : Effect of seasonal variation on the timing (shown in days following initial seeding), the height of the peak, and the final attack rate.We predict that, in the absence of control measures and with no seasonality in transmission, the introduction of CoVID-19 in England and Wales has the potential to result in a synchronised outbreak that peaks at around 4 months following the start of person-to-person transmission. Our findings suggest that the height of the epidemic and the attack rate is highly dependent on seasonality of transmission and that even small changes in transmission risk can lead to large changes in attack rate due to the spatial disaggregation of the population at risk.A combination of control measures and seasonal changes in transmission rate could shift the peak of the outbreak to the winter of 2020/21, with little effect on the final attack rate. If contact tracing and isolation efforts succeed in reducing transmission, but are unable to control the epidemic (9), an additional influx of severe CoVID-19 cases may exacerbate existing challenges with winter healthcare demand. A careful analysis of the impact of control measures on the timing of incidence of severe cases is warranted.The strength of this model lies in the spatial heterogeneity which tempers transmission. As a comparison, an equivalent non-spatial model results in the epidemic peaking after 34 days, nearly four times faster than this spatial model, and would be unable to capture the interaction between spatial transmission and seasonality. The estimated total number of people infected in the spatial model is marginally smaller than for a non-spatial model, as the infection has the opportunity to die-out in local parts of the country. As the model framework was developed and published in 2009, it was possible to re-deploy the model for these new circumstances; developing such a model from scratch during an outbreak would be a significant challenge.A key element missing from our model is morbidity, mortality and the treatment of cases. The model in its current form predicts the total number of infections in the community rather than diagnosed cases. Observations from China suggest that many cases have mild symptoms and that only around 5% of cases have been reported and diagnosed (3) . The parameter estimates we used from China appear to be substantially different to previous coronaviruses (6) . Should CoVID-19 continue spreading the UK it will become possible to get UK-specific parameter estimates and improve prediction accuracy.As with all modelling, it is impossible to capture the full complexity of an epidemic. In this model, the major assumptions are that we have assumed that there is no change in behaviour during the course of the epidemic. In practice, as the epidemic starts spreading in England and Wales there may well be a systematic change in behaviour as was seen during the H1N1 influenza pandemic in 2009. We have not included any age-effects, such as differential mixing, susceptibility or infectiousness. That means that we are not able to investigate the impact of school closures or the impact of the summer holidays, which had a large impact on the H1N1 influenza pandemic in 2009.']\n"
     ]
    }
   ],
   "source": [
    "#Second way to make dtm\n",
    "#extract bodt_text from datafrome to a list\n",
    "body_text_list = final_df[\"body_text\"].to_list()\n",
    "print(body_text_list[0:3])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\ProgramData\\Anaconda3\\lib\\site-packages\\sklearn\\feature_extraction\\text.py:507: UserWarning: The parameter 'token_pattern' will not be used since 'tokenizer' is not None'\n",
      "  warnings.warn(\"The parameter 'token_pattern' will not be used\"\n",
      "C:\\ProgramData\\Anaconda3\\lib\\site-packages\\sklearn\\feature_extraction\\text.py:385: UserWarning: Your stop_words may be inconsistent with your preprocessing. Tokenizing the stop words generated tokens [\"'d\", \"'ll\", \"'re\", \"'ve\", 'abov', 'ani', 'becaus', 'befor', 'could', 'doe', 'dure', 'ha', 'hi', 'might', 'must', \"n't\", 'need', 'onc', 'onli', 'ourselv', 'sha', 'themselv', 'thi', 'veri', 'wa', 'whi', 'wo', 'would', 'yourselv'] not in stop_words.\n",
      "  'stop_words.' % sorted(inconsistent))\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "fit option has \n",
      " CountVectorizer(analyzer='word', binary=False, decode_error='strict',\n",
      "                dtype=<class 'numpy.int64'>, encoding='utf-8', input='content',\n",
      "                lowercase=True, max_df=1.0, max_features=2000, min_df=1,\n",
      "                ngram_range=(1, 1), preprocessor=None,\n",
      "                stop_words=['i', 'me', 'my', 'myself', 'we', 'our', 'ours',\n",
      "                            'ourselves', 'you', \"you're\", \"you've\", \"you'll\",\n",
      "                            \"you'd\", 'your', 'yours', 'yourself', 'yourselves',\n",
      "                            'he', 'him', 'his', 'himself', 'she', \"she's\",\n",
      "                            'her', 'hers', 'herself', 'it', \"it's\", 'its',\n",
      "                            'itself', ...],\n",
      "                strip_accents=None, token_pattern='(?u)\\\\b\\\\w\\\\w+\\\\b',\n",
      "                tokenizer=<function tokenize at 0x00000224C7C14A68>,\n",
      "                vocabulary=None)\n",
      "2020-04-12 22:14:06.301697 2020-04-12 22:15:12.593184 0:01:06.291487\n"
     ]
    }
   ],
   "source": [
    "start = datetime.now() \n",
    "\n",
    "# function for stemming all words and create the DTM after filtering the document  \n",
    "\n",
    "def stem_tokens(tokens, stemmer):\n",
    "    stemmed = []\n",
    "    for item in tokens:\n",
    "        stemmed.append(stemmer.stem(item))\n",
    "    return stemmed\n",
    "\n",
    "def tokenize(text):\n",
    "    tokens = nltk.word_tokenize(text)\n",
    "    stems = stem_tokens(tokens, stemmer)\n",
    "    return stems\n",
    "\n",
    "\n",
    "vect = CountVectorizer(tokenizer=tokenize, stop_words = en_stop, ngram_range= (1,1),max_features = 2000)\n",
    "print(\"fit option has \\n\" ,vect.fit(body_text_list))\n",
    "dtm = vect.transform(body_text_list)\n",
    "\n",
    "end = datetime.now()\n",
    "run_time = end-start\n",
    "print(start, end, run_time)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [],
   "source": [
    "final_df2 = pd.DataFrame(dtm.toarray(), columns=vect.get_feature_names())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(665, 2000)\n",
      "['-1', '.to', '0.1', '1980', '1981', '1982', '1983', '1984', '1a', '1b', '1c', '2', '2.', '2.2', '2.5', '20', '200', '2002', '2003', '2004', '2009', '2011', '2012', '2013', '2014', '2015', '2016', '2017', '2018', '2019', '2019-ncov', '2020', '2020.', '2c', '5.2', '7.5', '76', '87', '89', '94', '97', 'ab', 'abdomin', 'abil', 'abl', 'abnorm', 'abov', 'absenc', 'absolut', 'absorb', 'abstract', 'abund', 'acceler', 'accept', 'access', 'accompani', 'accord', 'account', 'accumul', 'accur', 'accuraci', 'ace2', 'achiev', 'acid', 'acquir', 'across', 'act', 'action', 'activ', 'actual', 'acut', 'ad', 'adapt', 'addit', 'address', 'adequ', 'adjust', 'administ', 'administr', 'admiss', 'admit', 'adopt', 'adult', 'advanc', 'advantag', 'advers', 'advis', 'aerosol', 'affect', 'affin', 'africa', 'african', 'age', 'agenc', 'agent', 'aggreg', 'agreement', 'aid', 'aim', 'air', 'airborn', 'airport', 'airway', 'aki', 'al', 'al.', 'alert', 'algorithm', 'align', 'allel', 'allow', 'almost', 'alon', 'along', 'alreadi', 'also', 'alt', 'alter', 'altern', 'although', 'alveolar', 'alway', 'america', 'amino', 'aminotransferas', 'among', 'amount', 'amplif', 'analys', 'analysi', 'analyt', 'analyz', 'and/or', 'ani', 'anim', 'annot', 'announc', 'annual', 'anoth', 'answer', 'anti-vir', 'antibiot', 'antibodi', 'antigen', 'antivir', 'anxieti', 'apach', 'appar', 'appear', 'appendix', 'appli', 'applic', 'approach', 'appropri', 'approv', 'approxim', 'april', 'ard', 'area', 'aris', 'around', 'arrest', 'arriv', 'arteri', 'articl', 'ascertain', 'asia', 'ask', 'aspect', 'assay', 'assembl', 'assess', 'assign', 'assist', 'associ', 'assum', 'assumpt', 'asymptomat', 'attach', 'attack', 'attempt', 'attend', 'attent', 'attenu', 'attribut', 'auc', 'australia', 'author', 'author/fund', 'autom', 'automat', 'autopsi', 'avail', 'averag', 'avian', 'avoid', 'awar', 'b', 'back', 'bacteri', 'bacteria', 'baidu', 'balanc', 'ban', 'barrier', 'base', 'baselin', 'basi', 'basic', 'bat', 'becam', 'becaus', 'becom', 'bed', 'befor', 'began', 'begin', 'behavior', 'behaviour', 'beij', 'believ', 'belong', 'benefit', 'besid', 'best', 'betacoronaviru', 'better', 'beyond', 'bia', 'bias', 'bilater', 'bind', 'biolog', 'biomark', 'biorxiv', 'bird', 'birth', 'bleed', 'block', 'blood', 'blue', 'board', 'bodi', 'bond', 'bootstrap', 'bound', 'bovin', 'brain', 'branch', 'breath', 'bring', 'buffer', 'build', 'built', 'bundl', 'burden', 'c', 'c-reactiv', 'ca', 'calcul', 'calibr', 'call', 'calv', 'came', 'camel', 'cancer', 'candid', 'cant', 'cantli', 'capabl', 'capac', 'captur', 'cardiac', 'cardiovascular', 'care', 'carri', 'carrier', 'case', 'caso', 'cat', 'categor', 'categori', 'cathet', 'cattl', 'caus', 'caviti', 'cc-bi', 'cc-by-nc', 'cc-by-nc-nd', 'cc-by-nd', 'cd3', 'cd4', 'cd8', 'cdc', 'cell', 'cellular', 'center', 'centr', 'central', 'certain', 'cfr', 'chain', 'challeng', 'chanc', 'chang', 'channel', 'character', 'characterist', 'check', 'chemic', 'chen', 'chest', 'child', 'children', 'china', 'chines', 'chloroquin', 'choic', 'chosen', 'chronic', 'ci', 'circul', 'citi', 'civet', 'class', 'classic', 'classif', 'classifi', 'clean', 'clear', 'clearanc', 'clearli', 'cleavag', 'clinic', 'clinician', 'clone', 'close', 'closer', 'closur', 'cluster', 'cm', 'co', 'coagul', 'code', 'coeffici', 'cohort', 'cold', 'coli', 'collabor', 'colleagu', 'collect', 'color', 'column', 'combin', 'come', 'commerci', 'commiss', 'committe', 'common', 'commonli', 'commun', 'comorbid', 'compar', 'comparison', 'compart', 'compet', 'complet', 'complex', 'complianc', 'complic', 'compon', 'composit', 'compound', 'comprehens', 'compris', 'comput', 'con', 'concentr', 'concept', 'concern', 'conclud', 'conclus', 'condit', 'conduct', 'confer', 'confid', 'confin', 'confirm', 'conflict', 'conform', 'connect', 'consecut', 'consensu', 'consent', 'consequ', 'conserv', 'consid', 'consider', 'consist', 'consolid', 'constant', 'constitut', 'construct', 'consult', 'contact', 'contagi', 'contain', 'contamin', 'content', 'context', 'continu', 'contract', 'contrast', 'contribut', 'control', 'convalesc', 'convent', 'converg', 'convers', 'convert', 'coordin', 'copd', 'cope', 'copi', 'copyright', 'core', 'coronaviru', 'coronavirus', 'correct', 'correl', 'correspond', 'corticosteroid', 'cost', 'cough', 'could', 'count', 'countri', 'coupl', 'cours', 'cov', 'cover', 'coverag', 'covid-19', 'covid-2019', 'covid19', 'cr3022', 'creat', 'creatinin', 'crew', 'cri', 'crisi', 'criteria', 'critic', 'cross', 'crp', 'crrna', 'crucial', 'cruis', 'crystal', 'cshg', 'ct', 'cultur', 'cumul', 'cure', 'current', 'curv', 'cutoff', 'cvl218', 'cycl', 'cytokin', 'd-dimer', 'daili', 'damag', 'dan', 'data', 'databas', 'dataset', 'date', 'day', 'de', 'dead', 'deal', 'death', 'decad', 'decemb', 'decis', 'declar', 'declin', 'decreas', 'deep', 'defi', 'defici', 'defin', 'definit', 'degre', 'dehydrogenas', 'del', 'delay', 'deliv', 'deliveri', 'demand', 'demograph', 'demonstr', 'denot', 'densiti', 'dental', 'denv', 'depart', 'depend', 'depict', 'deplet', 'depress', 'deriv', 'describ', 'descript', 'design', 'despit', 'destin', 'detail', 'detect', 'deterior', 'determin', 'develop', 'deviat', 'devic', 'diabet', 'diagnos', 'diagnosi', 'diagnost', 'diamond', 'diarrhea', 'die', 'diff', 'differ', 'differenti', 'difficult', 'difficulti', 'diffus', 'dilut', 'direct', 'directli', 'discharg', 'discov', 'discoveri', 'discuss', 'diseas', 'disinfect', 'disord', 'dispers', 'display', 'disrupt', 'dissemin', 'distanc', 'distinct', 'distinguish', 'distress', 'distribut', 'divers', 'divid', 'dna', 'dock', 'doctor', 'document', 'doe', 'doi', 'domain', 'domest', 'domin', 'done', 'donor', 'dose', 'doubl', 'dramat', 'draw', 'dri', 'drive', 'drop', 'droplet', 'drug', 'due', 'durat', 'dure', 'dynam', 'dysfunct', 'dyspnea', 'e', 'e.', 'e.g', 'e.g.', 'ear', 'earli', 'earlier', 'earliest', 'easi', 'easili', 'east', 'eav', 'ebola', 'ecmo', 'econom', 'ect', 'ed', 'edit', 'educ', 'eff', 'effect', 'efficaci', 'effici', 'effort', 'eg', 'egg', 'eight', 'either', 'el', 'elderli', 'electron', 'element', 'elev', 'elimin', 'elisa', 'elsewher', 'emerg', 'emot', 'empir', 'employ', 'en', 'enabl', 'encod', 'encount', 'encourag', 'end', 'endpoint', 'energi', 'enhanc', 'enlarg', 'enough', 'enrich', 'enrol', 'ensur', 'enter', 'entir', 'entiti', 'entri', 'envelop', 'environ', 'environment', 'enzym', 'epicent', 'epidem', 'epidemiolog', 'epitheli', 'epitop', 'eq', 'eqcxcl16', 'equal', 'equat', 'equip', 'equival', 'erenc', 'error', 'es', 'especi', 'essenti', 'est', 'establish', 'estim', 'et', 'etc', 'ethic', 'etiolog', 'europ', 'european', 'evalu', 'even', 'event', 'eventu', 'everi', 'evid', 'evolut', 'evolutionari', 'evolv', 'exact', 'examin', 'exampl', 'exceed', 'excel', 'except', 'excess', 'exclud', 'exclus', 'exercis', 'exhibit', 'exist', 'expand', 'expect', 'experi', 'experienc', 'experiment', 'expert', 'explain', 'explor', 'exponenti', 'export', 'expos', 'exposur', 'express', 'extend', 'extens', 'extent', 'extracorpor', 'extract', 'extrem', 'eye', 'f', 'face', 'facemask', 'facil', 'facilit', 'fact', 'factor', 'fail', 'failur', 'fall', 'fals', 'famili', 'far', 'farm', 'fast', 'faster', 'fatal', 'fatigu', 'favor', 'fear', 'feasibl', 'featur', 'feb', 'feb.', 'februari', 'fecal', 'fece', 'feed', 'femal', 'ferret', 'festiv', 'fever', 'fewer', 'fi', 'field', 'fig', 'figur', 'file', 'filter', 'final', 'find', 'first', 'firstli', 'fish', 'fisher', 'fit', 'five', 'fix', 'fl', 'flexibl', 'flight', 'flow', 'fluctuat', 'fluid', 'focu', 'focus', 'follow', 'follow-up', 'food', 'forc', 'forecast', 'foreign', 'form', 'format', 'former', 'formula', 'found', 'four', 'fraction', 'fragment', 'frame', 'framework', 'franc', 'free', 'frequenc', 'frequent', 'full', 'fulli', 'function', 'fund', 'furthermor', 'fusion', 'futur', 'g', 'ga', 'gain', 'gamma', 'gap', 'gastrointestin', 'gather', 'genbank', 'gender', 'gene', 'gener', 'genet', 'genom', 'genu', 'geograph', 'germani', 'get', 'ggo', 'give', 'given', 'gland', 'glass', 'global', 'glove', 'glucos', 'glycoprotein', 'go', 'goal', 'good', 'govern', 'gradual', 'grant', 'great', 'greater', 'greatli', 'green', 'ground', 'ground-glass', 'group', 'grow', 'growth', 'guangdong', 'guid', 'guidanc', 'guidelin', 'h', 'h1n1', 'h7n9', 'ha', 'half', 'hand', 'handl', 'happen', 'hazard', 'hcov', 'hcw', 'headach', 'health', 'health-car', 'healthcar', 'healthi', 'heart', 'heat', 'help', 'hemodynam', 'hemorrhag', 'henc', 'hepat', 'herp', 'heterogen', 'hi', 'high', 'high-risk', 'higher', 'highest', 'highli', 'highlight', 'histor', 'histori', 'holder', 'holiday', 'home', 'homogen', 'homolog', 'hong', 'hope', 'hors', 'hospit', 'host', 'hour', 'household', 'howev', 'hr', 'http', 'huanan', 'hubei', 'huge', 'human', 'human-to-human', 'humid', 'hygien', 'hypertens', 'hypothes', 'hypothesi', 'i.e', 'i.e.', 'icu', 'id', 'ident', 'identif', 'identifi', 'ifn', 'igg', 'igm', 'ii', 'iii', 'il-6', 'ill', 'illustr', 'imag', 'immedi', 'immun', 'immunosuppress', 'impact', 'impair', 'implement', 'impli', 'implic', 'import', 'importantli', 'impos', 'improv', 'in-hospit', 'inc.', 'incid', 'incis', 'includ', 'inclus', 'incorpor', 'increas', 'incub', 'inde', 'independ', 'index', 'indic', 'individu', 'induc', 'infant', 'infect', 'infecti', 'infer', 'infiltr', 'infl', 'inflamm', 'inflammatori', 'influenc', 'influenza', 'inform', 'infus', 'inhibit', 'inhibitor', 'initi', 'injuri', 'innat', 'input', 'insert', 'insid', 'insight', 'instanc', 'instead', 'institut', 'instruct', 'instrument', 'insuffici', 'integr', 'intens', 'interact', 'interest', 'interestingli', 'interfac', 'interferon', 'intermedi', 'intern', 'internet', 'interpret', 'interquartil', 'interv', 'intervent', 'intestin', 'intraven', 'introduc', 'introduct', 'intub', 'invas', 'investig', 'involv', 'iqr', 'iran', 'irf3', 'isol', 'issu', 'itali', 'item', 'iv', 'j', 'jan', 'jan.', 'januari', 'japan', 'journal', 'k', 'keep', 'key', 'kidney', 'kinas', 'kind', 'kit', 'know', 'knowledg', 'known', 'kong', 'korea', 'l', 'la', 'label', 'laboratori', 'laboratory-confirm', 'lack', 'lactat', 'lag', 'lamp', 'larg', 'larger', 'largest', 'last', 'late', 'latent', 'later', 'latest', 'latter', 'layer', 'le', 'lead', 'learn', 'least', 'leav', 'led', 'left', 'length', 'lesion', 'less', 'level', 'li', 'librari', 'licens', 'life', 'light', 'like', 'likelihood', 'limit', 'line', 'linear', 'link', 'list', 'literatur', 'littl', 'live', 'liver', 'lo', 'load', 'lobe', 'local', 'locat', 'lockdown', 'log', 'logist', 'long', 'long-term', 'longer', 'look', 'lopinavir/ritonavir', 'loss', 'low', 'lower', 'lowest', 'lung', 'lymphocyt', 'lymphopenia', 'macrophag', 'made', 'magnitud', 'main', 'mainland', 'mainli', 'maintain', 'major', 'make', 'male', 'mammal', 'manag', 'mani', 'manifest', 'manner', 'manual', 'manufactur', 'manuscript', 'map', 'march', 'mark', 'marker', 'market', 'mask', 'mass', 'massiv', 'match', 'materi', 'matern', 'mathemat', 'matrix', 'matter', 'matur', 'maxim', 'maximum', 'may', 'mean', 'meanwhil', 'measur', 'mechan', 'media', 'median', 'mediat', 'medic', 'medicin', 'medium', 'medrxiv', 'meet', 'member', 'membran', 'men', 'mental', 'mention', 'mer', 'mers-cov', 'met', 'metabol', 'method', 'mg', 'mhc', 'mice', 'middl', 'might', 'migrat', 'mild', 'million', 'min', 'minim', 'minimum', 'ministri', 'minut', 'miss', 'mitig', 'mix', 'ml', 'mm', 'mmhg', 'mmol/l', 'mobil', 'mode', 'model', 'moder', 'modifi', 'modul', 'molecul', 'molecular', 'monitor', 'monoclon', 'month', 'morbid', 'moreov', 'mortal', 'mostli', 'mother', 'motif', 'mous', 'move', 'movement', 'msc', 'much', 'multipl', 'multivari', 'municip', 'muscl', 'must', 'mutant', 'mutat', 'mv', 'myalgia', 'myocardi', 'n', \"n't\", 'name', 'nasal', 'nasopharyng', 'nasopharynx', 'nation', 'nationwid', 'natur', 'ncbi', 'ncp', 'near', 'nearli', 'necessari', 'need', 'neg', 'neonat', 'network', 'neurolog', 'neutral', 'neutrophil', 'never', 'nevertheless', 'new', 'newli', 'news', 'next', 'nine', 'niv', 'nlr', 'nm', 'node', 'non-invas', 'non-sever', 'none', 'normal', 'nosocomi', 'notabl', 'note', 'notic', 'novel', 'np', 'nt', 'nucleic', 'nucleotid', 'number', 'numer', 'nurs', 'nutrit', 'object', 'observ', 'obstruct', 'obtain', 'obviou', 'occur', 'occurr', 'odd', 'offer', 'offic', 'offici', 'often', 'old', 'older', 'onc', 'one', 'ongo', 'onli', 'onlin', 'onset', 'onward', 'opac', 'open', 'oper', 'opportun', 'optim', 'option', 'oral', 'order', 'organ', 'organis', 'origin', 'otherwis', 'otu', 'outbreak', 'outcom', 'output', 'outsid', 'overal', 'overlap', 'ow', 'oxygen', 'p', 'p-valu', 'packag', 'pain', 'pair', 'pandem', 'panel', 'pangolin', 'pao', 'paper', 'parallel', 'paramet', 'parent', 'part', 'partial', 'particip', 'particl', 'particular', 'particularli', 'pass', 'passeng', 'past', 'patchi', 'pathogen', 'pathogenesi', 'patholog', 'pathway', 'patient', 'pattern', 'pb', 'pcr', 'pct', 'pdb', 'peak', 'pediatr', 'pedv', 'peep', 'peer-review', 'peopl', 'peptid', 'per', 'percent', 'percentag', 'percentil', 'perform', 'perhap', 'period', 'peripher', 'permiss', 'permission.author/fund', 'permission.th', 'perpetu', 'perpetuity.i', 'perpetuity.th', 'persist', 'person', 'person-to-person', 'personnel', 'ph', 'phase', 'phenomenon', 'phenotyp', 'phylogenet', 'physic', 'physician', 'physiolog', 'pig', 'place', 'plan', 'plasma', 'plasmid', 'plate', 'platelet', 'platform', 'plausibl', 'play', 'pleural', 'plot', 'plu', 'pneumonia', 'point', 'poisson', 'polici', 'polymeras', 'pool', 'poor', 'popul', 'pose', 'posit', 'possibl', 'post', 'posterior', 'postop', 'potent', 'potenti', 'power', 'ppe', 'practic', 'precaut', 'precis', 'predict', 'predictor', 'prefer', 'pregnanc', 'pregnant', 'preliminari', 'prepar', 'prepared', 'preprint', 'presenc', 'present', 'pressur', 'presum', 'preval', 'prevent', 'previou', 'previous', 'primari', 'primarili', 'primer', 'princess', 'princip', 'principl', 'prior', 'prioriti', 'pro', 'probabl', 'probe', 'problem', 'procalcitonin', 'procedur', 'process', 'produc', 'product', 'profession', 'profil', 'prognosi', 'prognost', 'program', 'progress', 'project', 'prolong', 'promis', 'promot', 'proper', 'properti', 'prophylaxi', 'proport', 'propos', 'prospect', 'proteas', 'protect', 'protein', 'protocol', 'prove', 'provid', 'provinc', 'provinci', 'proxi', 'proxim', 'psycholog', 'public', 'publicli', 'publish', 'pulmonari', 'purifi', 'purpos', 'put', 'q', 'qualiti', 'quantifi', 'quantit', 'quantiti', 'quarantin', 'que', 'question', 'questionnair', 'quickli', 'quit', 'r', 'r0', 'radiograph', 'radiolog', 'rais', 'random', 'randomli', 'rang', 'rank', 'rapid', 'rapidli', 'rare', 'rat', 'rate', 'ratg13', 'rather', 'ratio', 'raw', 'rbd', 'rd', 'rdrp', 'reach', 'reaction', 'reactiv', 'read', 'readili', 'reagent', 'real', 'real-tim', 'reason', 'receiv', 'recent', 'receptor', 'recipi', 'recogn', 'recognit', 'recombin', 'recommend', 'reconstruct', 'record', 'recov', 'recoveri', 'recruit', 'rectal', 'red', 'reduc', 'reduct', 'refer', 'reflect', 'regard', 'region', 'regress', 'regul', 'regular', 'regulatori', 'rel', 'relat', 'relationship', 'relax', 'releas', 'relev', 'reli', 'reliabl', 'remain', 'remdesivir', 'remov', 'renal', 'repeat', 'replac', 'replic', 'report', 'repres', 'reproduct', 'republ', 'requir', 'research', 'resembl', 'reserv', 'reservoir', 'resid', 'residu', 'resist', 'resolut', 'resolv', 'resourc', 'respect', 'respir', 'respiratori', 'respond', 'respons', 'rest', 'restrict', 'result', 'resuscit', 'retriev', 'retrospect', 'return', 'reus', 'reveal', 'revers', 'review', 'revis', 'ribavirin', 'right', 'rise', 'risk', 'rna', 'robust', 'role', 'room', 'rout', 'routin', 'rst', 'rt-lamp', 'rt-pcr', 'rt-qpcr', 'rule', 'run', 's1', 's2', 's3', 'safe', 'safeti', 'salin', 'sampl', 'sar', 'sars-cov', 'sars-cov-2', 'sars-lik', 'sarsr-cov', 'satur', 'scale', 'scan', 'scenario', 'school', 'scienc', 'scientif', 'scientist', 'score', 'screen', 'sd', 'se', 'seafood', 'search', 'season', 'second', 'secondari', 'secret', 'section', 'secur', 'sedat', 'see', 'seek', 'seem', 'seen', 'segment', 'seir', 'select', 'sens', 'sensit', 'sent', 'separ', 'sepsi', 'septic', 'sequenc', 'sequenti', 'seri', 'serial', 'seriou', 'serolog', 'serum', 'serv', 'server', 'servic', 'set', 'seven', 'sever', 'sex', 'shanghai', 'shape', 'share', 'shed', 'shenzhen', 'shift', 'ship', 'shock', 'short', 'shortag', 'shorter', 'show', 'shown', 'si', 'side', 'sign', 'signal', 'signifi', 'signific', 'significantli', 'similar', 'similarli', 'simpl', 'simpli', 'simul', 'simultan', 'sinc', 'singapor', 'singl', 'sink', 'sir', 'site', 'situat', 'six', 'size', 'skin', 'sleep', 'slightli', 'slow', 'small', 'smaller', 'social', 'societi', 'sofa', 'softwar', 'solut', 'solv', 'soon', 'sore', 'sourc', 'south', 'space', 'spatial', 'speci', 'special', 'specif', 'specifi', 'specimen', 'spectrum', 'specul', 'speed', 'spike', 'spontan', 'spread', 'spring', 'spss', 'sputum', 'squar', 'st', 'stabil', 'stabl', 'staff', 'stage', 'stand', 'standard', 'start', 'state', 'statist', 'statu', 'stay', 'step', 'still', 'stimul', 'stochast', 'stool', 'stop', 'store', 'storm', 'strain', 'strategi', 'stratifi', 'strength', 'strengthen', 'stress', 'strict', 'strong', 'strongli', 'structur', 'student', 'studi', 'subclin', 'subgroup', 'subject', 'submit', 'subsequ', 'subset', 'substanti', 'substitut', 'subunit', 'success', 'suffer', 'suffici', 'suggest', 'suitabl', 'sum', 'summar', 'summari', 'supplement', 'supplementari', 'suppli', 'support', 'suppress', 'surfac', 'surgeri', 'surgic', 'surround', 'surveil', 'survey', 'surviv', 'survivor', 'suscept', 'suspect', 'sustain', 'sutur', 'swab', 'swine', 'symptom', 'symptomat', 'syndrom', 'synthes', 'synthesi', 'synthet', 'system', 'systemat', 'tabl', 'taiwan', 'take', 'taken', 'target', 'team', 'technic', 'techniqu', 'technolog', 'temperatur', 'templat', 'tempor', 'ten', 'tend', 'term', 'termin', 'tertiari', 'test', 'text', 'th', 'thailand', 'themselv', 'theoret', 'theori', 'therapeut', 'therapi', 'therebi', 'therefor', 'thi', 'thicken', 'third', 'though', 'thought', 'thousand', 'threat', 'three', 'threshold', 'throat', 'throughout', 'thu', 'time', 'tissu', 'tmprss2', 'togeth', 'took', 'tool', 'top', 'total', 'toward', 'trace', 'tracheostomi', 'track', 'tract', 'tradit', 'traffic', 'train', 'trajectori', 'transcript', 'transfer', 'transfus', 'transit', 'translat', 'transmiss', 'transmit', 'transplant', 'transport', 'trauma', 'traumat', 'travel', 'treat', 'treatment', 'tree', 'trend', 'tri', 'trial', 'trigger', 'true', 'tube', 'tumor', 'turn', 'twice', 'two', 'type', 'typic', 'u', 'uid', 'uk', 'ultim', 'ultrasound', 'un', 'unabl', 'uncertainti', 'unclear', 'underestim', 'undergo', 'underli', 'understand', 'underw', 'undetect', 'unfortun', 'uniqu', 'unit', 'univers', 'unknown', 'unless', 'unlik', 'updat', 'upon', 'upper', 'urban', 'urgent', 'urin', 'us', 'usa', 'use', 'user', 'usual', 'util', 'v', 'vaccin', 'valid', 'valu', 'valuabl', 'vap', 'vari', 'variabl', 'varianc', 'variant', 'variat', 'varieti', 'variou', 'vector', 'venou', 'ventil', 'veri', 'verifi', 'version', 'versu', 'vertic', 'via', 'view', 'viral', 'virion', 'viru', 'virul', 'virus', 'visit', 'visual', 'vital', 'vitro', 'vivo', 'volum', 'vs', 'vs.', 'vt', 'vulner', 'wa', 'wall', 'wang', 'ward', 'wash', 'water', 'wave', 'way', 'weak', 'wean', 'wear', 'websit', 'week', 'weight', 'well', 'wet', 'wherea', 'whether', 'whi', 'whilst', 'white', 'whole', 'wholesal', 'whose', 'wide', 'widespread', 'wild', 'window', 'within', 'without', 'women', 'word', 'work', 'worker', 'world', 'worldwid', 'wors', 'worsen', 'worth', 'would', 'write', 'written', 'wuhan', 'x', 'x-ray', 'year', 'yet', 'yield', 'young', 'younger', 'z', 'zero', 'zhejiang', 'zone', 'zoonot', 'µ', 'κ', 'μl']\n"
     ]
    }
   ],
   "source": [
    "print(dtm.shape)\n",
    "print(vect.get_feature_names())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 69,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'list'>\n",
      "665\n"
     ]
    }
   ],
   "source": [
    "#extract body text from filtering dataset\n",
    "\n",
    "\n",
    "bodytext = (final_df[\"body_text\"].values).tolist() #convert values to list of lists (each row becomes a separate list) \n",
    "print(type(bodytext))\n",
    "print(len(bodytext))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "[['sudden', 'outbreak', 'new', 'coronaviru', 'sar', 'cov', '2', 'end', 'decemb', '2019', 'pose', 'huge', 'threat', 'human', 'health', 'worldwid', 'sar', 'cov', '2', 'viru', 'caus', 'sever', 'respiratori', 'diseas', 'quickli', 'spread', 'person', 'person', 'case', 'lead', 'death', 'research', 'found', 'new', 'sar', 'cov', '2', 'sar', 'coronavirus', 'invad', 'human', 'cell', 'target', 'tissu', 'similar', 'manner', 'via', 'high', 'affin', 'bind', 'angiotensin', 'convert', 'enzym', '2', 'ace2', 'recent', 'epidemiolog', 'investig', 'spread', 'sar', 'cov', '2', 'preliminari', 'studi', 'clinic', 'characterist', 'diseas', '2', 'research', 'found', 'patient', 'infect', 'new', 'coronaviru', 'sever', 'symptom', 'similar', 'sar', 'infect', 'first', 'batch', 'clinic', 'data', 'report', 'sar', 'cov', '2', 'infect', 'case', 'china', 'reveal', 'cytokin', 'storm', 'critic', 'ill', 'patient', 'howev', 'mechan', 'viral', 'infect', 'patholog', 'chang', 'immun', 'system', 'still', 'lack', 'sooner', 'inform', 'ad', 'current', 'clinic', 'knowledg', 'virus', 'better', 'control', 'treatment', 'diseas', 'present', 'autom', 'topic', 'wise', 'infer', 'method', 'call', 'twirl', 'topic', 'wise', 'infer', 'engin', 'massiv', 'biomed', 'literatur', 'process', 'massiv', 'biomed', 'literatur', 'summar', 'coronaviru', 'host', 'relat', 'entiti', 'twirl', 'capabl', 'collect', 'classifi', 'analyz', 'report', 'coronaviru', 'studi', 'reveal', 'entiti', 'base', 'distribut', 'specif', 'gene', 'text', 'articl', 'combin', 'gener', 'protein', 'interact', 'data', 'link', 'certain', 'function', 'cellular', 'physiolog', 'compon', 'infer', 'fill', 'knowledg', 'gap', 'probabl', 'mechan', 'host', 'patholog', 'chang', 'eventu', 'lead', 'acut', 'lung', 'injuri', 'host', 'therefor', 'twirl', 'use', 'guid', 'human', 'research', 'provid', 'potenti', 'therapeut', 'target', 'inform', 'treatment', 'acut', 'viral', 'lung', 'injuri', 'base', 'regul', 'ra', 'coronaviru', 'studi', 'specif', 'entiti', 'host', 'gene', 'februari', '2020', 'pubm', 'databas', 'includ', '878', 'biomed', 'articl', 'coronavirus', 'obtain', 'text', 'data', 'call', 'local', 'sampl', 'relat', 'articl', 'coronaviru', 'peer', 'review', 'publish', 'human', 'expert', 'includ', 'titl', 'abstract', 'author', 'affili', 'inform', 'total', '182', '687', 'word', 'goal', 'literatur', 'mine', 'identifi', 'host', 'gene', 'entiti', 'relev', 'coronaviru', 'research', 'establish', 'connect', 'entiti', 'refer', 'word', 'phrase', 'concept', 'name', 'includ', 'relat', 'concept', 'e', 'g', 'viru', 'structur', 'chemic', 'composit', 'sourc', 'infect', 'viru', 'type', 'gene', 'name', 'defin', 'use', 'mammalian', 'offici', 'gene', 'symbol', 'hugo', 'gene', 'name', 'committe', 'hgnc', 'databas', 'directli', 'retriev', '667', 'candid', 'gene', 'local', 'sampl', 'establish', 'random', 'distribut', 'one', 'candid', 'gene', 'control', 'sampl', 'signific', 'gene', 'appear', 'local', 'sampl', 'determin', 'frequenc', 'current', 'gene', 'outlier', 'random', 'distribut', 'control', 'sampl', 'see', 'method', 'detail', 'calcul', 'odd', 'ratio', 'also', 'determin', 'specif', 'associ', 'gene', 'local', 'sampl', 'paper', 'select', 'odd', 'ratio', 'threshold', 'judgment', 'result', '123', 'coronaviru', 'studi', 'specif', 'host', 'gene', 'cshg', 'determin', 'specif', 'entiti', 'made', 'choic', 'differ', 'text', 'local', 'sampl', 'remov', 'number', 'symbol', 'verb', 'garbl', 'charact', 'obtain', 'clean', 'version', 'local', 'sampl', 'coronaviru', 'studi', 'specif', 'entiti', 'csse', 'identifi', 'clean', 'text', 'contain', 'cshg', 'base', 'clean', 'select', 'sampl', 'next', 'built', 'local', 'dictionari', 'candid', 'css', 'contain', '293', 'word', 'dedupl', 'calcul', 'random', 'distribut', 'entiti', 'includ', 'synonym', 'entiti', 'entiti', 'number', 'includ', 'singular', 'plural', 'word', 'activ', 'passiv', 'form', 'differ', 'tens', 'suffix', 'chang', 'mean', 'etc', 'exampl', 'synonym', 'entiti', 'coronavir', 'coronaviru', 'coronavirus', 'group', 'one', 'entiti', 'coronaviru', 'assign', 'number', 'see', 'entiti', 'number', 'tabl', 'S1', 'sheet', 'first', 'column', 'previou', 'method', 'merg', 'synonym', 'entiti', 'base', 'dictionari', 'reli', 'integr', 'dictionari', 'also', 'requir', 'long', 'retriev', 'time', 'automat', 'solv', 'synonym', 'entiti', 'problem', 'twirl', 'classifi', 'similar', 'string', 'base', 'whether', 'signific', 'statist', 'associ', 'charact', 'block', 'set', 'candid', 'entiti', 'includ', 'variou', 'synonym', 'entiti', 'see', 'method', 'clean', 'process', 'css', 'identifi', 'twirl', 'use', 'similar', 'method', 'cshg', 'describ', 'candid', 'csse', 'dictionari', 'random', 'distribut', 'model', 'entiti', 'built', 'twirl', 'use', 'control', 'sampl', 'identifi', '623', 'css', 'tabl', 'Sl', 'sheet', 'base', 'outlier', 'discrimin', 'random', 'model', 'calcul', 'odd', 'ratio', 'exampl', 'twirl', 'found', 'css', 'close', 'ace2', 'receptor', 'sar', 'sar', 'cov', '2', 'virus', 'see', 'left', 'panel', 'figur', 'size', 'entiti', 'repres', 'rel', 'distanc', 'ace2', 'larger', 'size', 'indic', 'closer', 'distanc', 'ace2', 'addit', 'present', 'csse', 'cloud', 'human', 'receptor', 'gene', 'dpp4', 'mer', 'viru', 'see', 'right', 'panel', 'figur', 'although', 'twirl', 'identifi', '623', 'css', 'collat', 'human', 'research', 'inform', 'scatter', 'word', 'limit', 'reconstruct', 'understand', 'mechanist', 'model', 'therefor', 'twirl', 'cluster', 'css', 'accord', 'rule', 'defin', 'cshg', 'distribut', 'genet', 'level', 'research', 'accur', 'answer', 'solv', 'physiolog', 'patholog', 'problem', 'twirl', 'first', 'calcul', 'specif', 'co', 'distribut', 'cshg', 'local', 'sampl', 'determin', 'distanc', 'pair', 'css', 'perform', 'dichotomi', 'cluster', 'accord', 'linkag', 'relationship', 'css', 'cshg', 'classifi', '623', 'entiti', 'categori', 'repres', 'C0', 'c31', 'see', 'categori', 'number', 'tabl', 'S1', 'sheet', 'second', 'column', 'addit', 'categori', 'twirl', 'also', 'cite', 'top', 'ten', 'relev', 'refer', 'human', 'research', 'tabl', 'S2', 'therefor', 'categori', 'accord', 'csse', 'relev', 'literatur', 'quickli', 'provid', 'label', 'conclus', 'drawn', 'human', 'research', 'HR', 'label', 'categori', 'label', 'outlin', 'relev', 'research', 'direct', 'current', 'entiti', 'categori', 'exampl', 'categori', 'C3', 'HR', 'label', 'neurotroph', 'coronaviru', 'relat', 'immun', 'mediat', 'demyelin', 'summar', 'HR', 'label', 'entiti', 'categori', 'tabl', 'rel', 'posit', 'cshg', 'certain', 'csse', 'estim', 'twirl', 'see', 'tabl', 'S1', 'rank', 'matrix', 'sheet', 'categori', 'contain', 'differ', 'entiti', 'determin', 'whether', 'certain', 'cshg', 'significantli', 'closer', 'entiti', 'current', 'categori', 'base', 'rank', 'matrix', 'cshg', 'csse', 'exampl', 'averag', 'distanc', 'ace2', 'entiti', 'categori', 'C5', 'first', 'calcul', 'random', 'distribut', 'model', 'averag', 'distanc', 'ace2', 'entiti', '3000', '5000', 'time', 'built', 'final', 'determin', 'averag', 'distanc', 'ace2', 'entiti', 'categori', 'C5', 'significantli', 'less', 'deviat', 'mean', 'random', 'distribut', 'Z', 'score', '8416', 'signific', 'categori', 'associ', 'cshg', 'score', 'twirl', 'rang', 'smaller', 'score', 'indic', 'current', 'cshg', 'relev', 'current', 'categori', 'see', 'Z', 'score', 'matrix', 'tabl', 'S1', 'sheet', '2', 'entiti', 'categori', 'associ', 'cshg', 'e', 'g', 'Ci', 'cshg', 'repres', 'categori', 'number', 'thu', 'select', 'Z', 'score', 'Z', 'score', 'describ', 'associ', 'cshg', 'categori', 'summar', 'sheet2', 'tabl', 'S1', 'categori', 'label', 'cshg', 'provid', 'sheet', 'specif', 'spike', 'protein', 'protein', 'differ', 'coronavirus', 'recogn', 'differ', 'receptor', 'molecul', 'human', 'cell', 'ace2', 'bind', 'spike', 'protein', 'sar', 'sar', 'cov', '2', 'viru', 'dpp4', 'bind', 'spike', 'protein', 'mer', 'viru', 'found', 'two', 'gene', 'assign', 'C5', 'categori', 'correspond', 'HR', 'label', 'spike', 'protein', 'coronaviru', 'suggest', 'twirl', 'automat', 'provid', 'interfac', 'summar', 'human', 'find', 'help', 'human', 'expert', 'quickli', 'understand', 'research', 'direct', 'necessari', 'knowledg', 'field', 'distribut', 'mean', 'data', 'compar', 'specif', 'express', 'valu', 'cshg', 'differ', 'condit', 'categori', 'use', 'condit', 'therefor', 'base', 'right', 'reserv', 'reus', 'allow', 'without', 'permiss', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'distribut', 'pathway', 'signatur', 'twirl', 'recommend', 'like', 'least', 'like', 'signal', 'pathway', 'tabl', '2', 'hand', 'twirl', 'also', 'recommend', 'like', 'least', 'like', 'categori', 'signal', 'pathway', 'exampl', 'tabl', 'show', 'signal', 'pathway', 'like', 'associ', 'categori', 'C3', 'unlik', 'correspond', 'categori', 'coupl', 'data', 'gene', 'interact', 'regul', 'databas', 'construct', 'gener', 'protein', 'protein', 'interact', 'network', 'ppi', 'network', 'among', '119', 'gene', '123', 'cshg', 'defin', 'direct', 'interact', 'two', 'gene', 'degre', 'interact', 'indirect', 'interact', 'connect', 'two', 'gene', 'gene', '2', 'degre', '2', 'interact', 'gene', 'network', 'mine', 'ppi', 'databas', 'shown', 'figur', '2', 'result', 'dedupl', 'show', '2', '004', 'pair', '119', 'cshg', 'see', 'tabl', 'S1', 'sheet', 'control', 'averag', 'interact', '119', 'randomli', 'select', 'gene', 'databas', 'show', '252', '612', 'pair', 'averag', '220', 'standard', 'deviat', 'compar', 'random', 'gene', 'regulatori', 'connect', 'cshg', 'significantli', 'enrich', 'Z', 'score', '97', 'cshg', 'associ', 'certain', 'categori', 'much', 'closer', 'interact', 'exampl', 'cshg', 'associ', 'categori', 'C3', 'associ', 'C5', 'c10', 'closer', 'network', 'figur', '2', 'suggest', 'twirl', 'possibl', 'highlight', 'import', 'research', 'direct', 'biolog', 'system', 'involv', 'coronaviru', 'specif', 'research', 'provid', 'reliabl', 'interfac', 'automat', 'infer', 'sever', 'hub', 'gene', 'among', '119', 'cshg', 'recommend', 'twirl', 'compar', 'random', 'sampl', 'interact', 'record', 'databas', 'hub', 'gene', 'significantli', 'increas', 'number', 'interact', '118', 'cshg', 'recommend', 'result', 'show', 'three', 'member', 'ifitm', 'famili', 'ifitm1', 'rank', 'first', 'second', 'sixth', 'among', 'top', 'ten', 'hub', 'gene', 'csse', 'cloud', 'ifitm', 'famili', 'gene', 'shown', 'figur', 'detail', 'rank', 'recommend', 'result', 'shown', 'tabl', 'S1', 'sheet', 'ifitm', 'gene', 'show', '115', 'interact', 'account', '338', 'interact', '119', 'cshg', 'ifitm', 'significantli', 'enrich', 'local', 'sampl', 'repres', 'updat', 'coronaviru', 'relat', 'right', 'reserv', 'reus', 'allow', 'without', 'permiss', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'studi', 'averag', '03', 'control', 'test', 'random', 'sampl', 'p', '5676e', 'ifitm', 'famili', 'play', 'crucial', 'role', 'induct', 'interferon', 'viral', 'infect', 'action', 'interferon', 'ifitm', 'disrupt', 'intracellular', 'cholesterol', 'homeostasi', 'prevent', 'viru', 'enter', 'host', 'cell', 'howev', 'twirl', 'directli', 'associ', 'ifitm', 'categori', 'need', 'provid', 'inform', 'twirl', 'determin', 'part', 'gene', 'might', 'involv', 'coronaviru', 'infect', 'host', 'bodi', 'respons', 'combin', 'gener', 'interact', 'databas', 'provid', 'richer', 'interact', 'regulatori', 'linkag', 'extend', '119', 'cshg', '2', 'network', 'base', 'interact', 'higher', 'likelihood', 'connect', 'combin', 'score', '800', '2', 'network', 'expand', 'number', 'gene', '119', 'host', 'gene', '494', 'gene', 'may', 'associ', 'coronaviru', 'see', 'tabl', 'S1', 'sheet', 'dpp4', 'differ', 'distribut', 'receptor', 'respiratori', 'tract', 'result', 'differ', 'degre', 'infect', 'although', 'infect', 'abil', 'mer', 'lower', 'sar', 'mortal', 'higher', 'one', 'third', 'patient', 'deeper', 'infect', 'site', 'similar', 'sar', 'viru', 'viral', 'genom', 'structur', 'biolog', 'studi', 'shown', 'ace2', 'also', 'function', 'receptor', 'new', 'sar', 'cov', '2', 'coronaviru', 'bind', 'ace2', 'via', 'spike', 'protein', 'sar', 'cov', '2', 'undergo', 'membran', 'fusion', 'enter', 'host', 'cell', 'endocytosi', 'ace2', 'peptidas', 'key', 'regul', 'renin', 'angiotensin', 'system', 'ra', 'highli', 'express', 'heart', 'kidney', 'testi', 'also', 'express', 'lower', 'level', 'tissu', 'mainli', 'intestin', 'lung', 'recent', 'studi', 'shown', 'bind', 'protein', 'ace2', 'new', 'coronaviru', '20', 'time', 'stronger', 'sar', 'viru', 'may', 'help', 'new', 'coronaviru', 'infect', 'host', 'upper', 'respiratori', 'tract', 'significantli', 'increas', 'infect', 'use', 'twirl', 'abl', 'identifi', 'ace2', 'dpp4', 'gene', 'cshg', 'significantli', 'associ', 'C5', 'categori', 'HR', 'label', 'categori', 'associ', 'protein', 'addit', 'ace2', 'dpp4', 'cshg', 'significantli', 'associ', 'C5', 'categori', 'includ', 'furin', 'tmprss2', 'former', 'may', 'requir', 'h7n1', 'h5n1', 'influenza', 'viru', 'infect', 'probabl', 'via', 'hemagglutinin', 'induc', 'lysi', 'wherea', 'latter', 'wide', 'report', 'mediat', 'assist', 'invas', 'host', 'cell', 'multipl', 'virus', 'transmembran', 'proteas', 'serin', '2', 'tmprss2', 'serin', 'proteas', 'hydrolyz', 'activ', 'spike', 'glycoprotein', 'human', 'coronaviru', '229e', 'hcov', '229e', 'human', 'coronaviru', 'emc', 'hcov', 'emc', 'sendai', 'viru', 'sev', 'human', 'interstiti', 'pneumoviru', 'hmpv', '2', 'fusion', 'glycoprotein', 'F0', '4a', '4b', 'human', 'parainfluenza', 'virus', 'hpiv', 'function', 'gene', 'essenti', 'transmiss', 'pathogenesi', 'influenza', 'virus', 'h1n1', 'h3n2', 'h7n9', 'strain', 'also', 'involv', 'hydrolysi', 'activ', 'hemagglutinin', 'protein', 'essenti', 'viral', 'infect', '20', 'although', 'entiti', 'C5', 'categori', 'cite', 'literatur', 'mainli', 'show', 'viru', 'invas', 'facilit', 'viru', 'bind', 'receptor', 'membran', 'proteas', 'biolog', 'mechan', 'receptor', 'bind', 'virus', 'lead', 'patholog', 'chang', 'report', 'less', 'frequent', 'right', 'reserv', 'reus', 'allow', 'without', 'permiss', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'twirl', 'recommend', 'new', 'gene', 'interact', 'C5', 'cshg', '2', 'csgh', 'link', 'gene', 'might', 'enrich', 'categori', 'infer', 'base', 'process', 'find', 'new', 'gene', 'connect', 'differ', 'categori', 'connect', 'categori', 'suggest', 'potenti', 'regulatori', 'relationship', 'differ', 'biolog', 'function', 'phenotyp', 'gene', 'serv', 'linker', 'potenti', 'target', 'gain', 'loss', 'function', 'experi', 'identifi', 'system', 'describ', 'meaning', 'entiti', 'categori', 'paper', 'twirl', 'found', '2', 'network', 'show', 'connect', 'certain', 'cshg', 'associ', 'categori', 'categori', 'exampl', 'twirl', 'found', 'cshg', '2', 'connect', 'ifitm1', 'mainli', 'concentr', 'C3', 'categori', 'see', 'figur', 'interestingli', 'cshg', '2', 'connect', 'ace2', 'dpp4', 'associ', 'C5', 'categori', 'also', 'enrich', 'C3', 'categori', 'infer', 'inform', 'summar', 'C3', 'categori', 'probabl', 'describ', 'underli', 'mechan', 'patholog', 'chang', 'coronaviru', 'infect', 'analysi', 'signal', 'pathway', 'C3', 'mainli', 'ra', 'vitamin', 'rxr', 'activ', 'chemokin', 'signal', 'ra', 'signific', 'shown', 'tabl', 'summar', 'C3', 'relat', 'signal', 'pathway', 'link', 'C3', 'associ', 'cytokin', 'includ', 'ccl5', 'cxcl1', 'cxcl10', 'cxcl11', 'cxcl2', 'cxcl9', 'cxcr2', 'cxcr3', 'figur', 'subsequ', 'linker', 'gene', 'may', 'contain', 'inform', 'biolog', 'mechan', 'may', 'import', 'understand', 'diseas', 'exampl', 'twirl', 'recommend', 'angiotensinogen', 'agt', 'angiotensin', 'II', 'receptor', 'type', '2', 'agtr2', 'at2r', 'gene', 'C3', 'categori', 'associ', 'ace2', 'support', 'ra', 'probabl', 'involv', 'patholog', 'chang', 'caus', 'cytokin', 'storm', 'protein', 'bind', 'ace2', 'suggest', 'report', 'next', 'use', 'twirl', 'calcul', '2', 'network', '119', 'cshg', 'base', 'significantli', 'enrich', 'categori', 'cshg', 'network', 'twirl', 'separ', 'construct', 'model', 'complex', 'relationship', 'cshg', 'found', 'right', 'reserv', 'reus', 'allow', 'without', 'permiss', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'cshg', 'network', 'associ', 'C3', 'c10', 'categori', 'five', 'gene', 'ccl3', 'ccl5', 'cxcl1', 'cxcl2', 'stat2', 'associ', 'suggest', 'biolog', 'mechan', 'describ', 'C3', 'c10', 'categori', 'might', 'univers', 'involv', 'research', 'entiti', 'gene', 'pathway', 'linker', 'gene', 'particip', 'C3', 'c10', 'categori', 'could', 'lead', 'new', 'direct', 'prevent', 'treatment', 'clinic', 'manag', 'coronaviru', 'infect', 'studi', 'use', 'twirl', 'machin', 'base', 'approach', 'collect', 'summar', 'analyz', '000', 'biomed', 'articl', 'relat', 'coronaviru', 'aim', 'elucid', 'mechan', 'underli', 'coronaviru', 'induc', 'host', 'patholog', 'chang', 'use', 'twirl', 'found', 'possibl', 'mechan', 'involv', 'ace2', 'at2r', 'ra', 'cytokin', 'signal', 'becom', 'imbalanc', 'viru', 'infect', 'lead', 'cytokin', 'storm', 'twirl', 'system', 'autom', 'process', 'summar', 'entiti', 'gene', 'specif', 'relat', 'coronavirus', 'combin', 'system', 'gener', 'interact', 'databas', 'reveal', 'associ', 'provid', 'deeper', 'understand', 'biolog', 'mechan', 'diseas', 'phenotyp', 'caus', 'viru', 'host', 'interact', 'viru', 'ace2', 'may', 'disrupt', 'balanc', 'caus', 'steadi', 'state', 'imbal', 'ra', 'lead', 'subsequ', 'patholog', 'chang', 'although', 'ang', 'II', 'origin', 'describ', 'effect', 'vasoconstrictor', 'grow', 'evid', 'close', 'involv', 'inflammatori', 'respons', 'immun', 'system', 'pro', 'inflammatori', 'cytokin', 'deriv', 'immun', 'cell', 'normal', 'regul', 'ra', 'compon', 'acceler', 'format', 'system', 'local', 'ang', 'II', 'particular', 'pro', 'inflammatori', 'cytokin', 'regul', 'product', 'agt', 'liver', 'kidney', 'hand', 'ra', 'also', 'implic', 'mediat', 'cytokin', 'storm', 'function', 'relationship', 'immun', 'system', 'angiotensin', 'II', 'regul', 'vascular', 'tension', 'stimul', 'releas', 'pro', 'inflammatori', 'cytokin', 'product', 'releas', 'cxc', 'chemokin', 'induc', 'accumul', 'neutrophil', 'vivo', 'meanwhil', 'ace', 'inhibitor', 'ang', 'II', 'receptor', 'blocker', 'use', 'number', 'cytokin', 'mediat', 'inflammatori', 'patholog', 'at1r', 'blocker', 'angiotensin', 'receptor', 'blocker', 'shown', 'benefici', 'effect', 'commonli', 'attribut', 'at2r', 'activ', 'time', 'report', 'ang', 'II', 'stimul', 'human', 'endotheli', 'cell', 'increas', 'releas', 'cxc', 'chemokin', 'IP', 'ifn', 'induc', 'protein', 'IP', 'cxcl10', 'mainli', 'express', 'lung', 'chemoattract', 'activ', 'cell', 'express', 'IP', 'observ', 'mani', 'th1', 'type', 'inflammatori', 'diseas', 'thought', 'play', 'import', 'role', 'recruit', 'activ', 'cell', 'site', 'tissu', 'inflamm', 'therefor', 'ra', 'dysfunct', 'may', 'result', 'accumul', 'cytokin', 'lung', 'lead', 'excess', 'accumul', 'immun', 'cell', 'interstiti', 'fluid', 'block', 'airway', 'caus', 'eventu', 'death', 'report', 'first', 'sever', 'infect', 'patient', 'diagnos', 'covid', 'larg', 'number', 'patient', 'experienc', 'cytokin', 'storm', 'fatal', 'figur', 'summar', 'function', 'chang', 'patholog', 'consequ', 'ra', 'system', 'ace2', 'combin', 'coronaviru', 'expect', 'mechan', 'summar', 'reason', 'twirl', 'support', 'patholog', 'evid', 'date', 'one', 'report', 'post', 'mortem', 'biopsi', 'publish', 'patholog', 'data', 'although', 'histolog', 'examin', 'show', 'bilater', 'diffus', 'alveolar', 'damag', 'cellular', 'fibromyxoid', 'exud', 'right', 'lung', 'show', 'evid', 'desquam', 'right', 'reserv', 'reus', 'allow', 'without', 'permiss', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'pneumocyt', 'hyalin', 'membran', 'format', 'indic', 'acut', 'respiratori', 'distress', 'syndrom', 'ard', 'wherea', 'left', 'lung', 'show', 'pulmonari', 'edema', 'hyalin', 'membran', 'format', 'suggest', 'earli', 'phase', 'ard', 'patholog', 'evid', 'suggest', 'ard', 'symptom', 'close', 'relat', 'cytokin', 'storm', 'howev', 'still', 'lack', 'histopatholog', 'relat', 'data', 'support', 'preliminari', 'find', 'gener', 'machin', 'approach', 'right', 'reserv', 'reus', 'allow', 'without', 'permiss', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprintw', 'use', 'pubm', 'wide', 'use', 'databas', 'biolog', 'literatur', 'resourc', 'text', 'mine', 'schemat', 'represent', 'overal', 'studi', 'design', 'shown', 'figur', 'summar', 'follow', 'step', 'dataset', 'use', 'pipelin', 'pubm', 'articl', 'first', 'pubm', 'search', 'articl', 'includ', 'titl', 'abstract', 'author', 'affili', 'inform', 'contain', 'subject', 'keyword', 'coronaviru', 'search', 'result', 'download', 'txt', 'format', 'compil', 'structur', 'inform', 'text', 'subject', 'abstract', 'set', 'organ', 'clean', 'assign', 'specif', 'corpus', 'relat', 'coronaviru', 'specif', 'corpu', 'compil', 'subject', 'dictionari', 'enhanc', 'accuraci', 'effect', 'entiti', 'associ', 'keyword', 'use', 'random', 'corpu', 'comparison', 'search', 'articl', 'abstract', 'contain', 'keyword', 'public', 'health', 'compil', 'abstract', 'set', 'random', 'corpu', 'compil', 'random', 'control', 'dictionari', 'contain', 'wide', 'rang', 'protein', 'gene', 'relat', 'biolog', 'entiti', 'also', 'consid', 'balanc', 'amount', 'inform', 'set', 'relev', 'paramet', 'adjust', 'amount', 'text', 'carri', 'statist', 'analys', 'biolog', 'entiti', 'identif', 'key', 'step', 'literatur', 'mine', 'process', 'ensur', 'function', 'extract', 'entiti', 'first', 'compar', 'entiti', 'subject', 'dictionari', 'human', 'offici', 'gene', 'symbol', 'hugo', 'gene', 'nomenclatur', 'commiss', 'hgnc', 'databas', 'gener', 'subject', 'candid', 'gene', 'use', 'standard', 'nomenclatur', 'addit', 'entiti', 'abstract', 'capit', 'avoid', 'error', 'identif', 'process', 'obtain', 'wide', 'use', 'gene', 'entiti', 'precis', 'relat', 'subject', 'determin', 'signific', 'gene', 'distribut', 'specif', 'text', 'calcul', 'differ', 'distribut', 'proport', 'search', 'subject', 'candid', 'gene', 'subject', 'dictionari', 'random', 'control', 'dictionari', 'respect', 'also', 'count', 'number', 'abstract', 'contain', 'subject', 'candid', 'gene', 'abstract', 'set', 'respect', 'final', 'calcul', 'odd', 'ratio', 'subject', 'candid', 'gene', 'sort', 'list', 'precis', 'relat', 'gene', 'cshg', 'similar', 'process', 'identifi', 'cshg', 'calcul', 'whether', 'entiti', 'significantli', 'distribut', 'specif', 'corpu', 'count', 'number', 'text', 'contain', 'cshg', 'specif', 'corpu', 'count', 'number', 'candid', 'entiti', 'corpu', 'subset', 'next', 'randomli', 'select', 'amount', 'text', 'random', 'control', 'corpu', 'count', 'number', 'candid', 'entiti', 'subset', 'random', 'corpu', 'repeat', '10000', 'time', 'random', 'corpu', 'gener', 'candid', 'entiti', 'specifi', 'amount', 'text', 'random', 'distribut', 'model', 'accord', 'central', 'limit', 'theorem', 'clt', 'distribut', 'random', 'sampl', 'averag', 'randomli', 'distribut', 'data', 'alway', 'conform', 'normal', 'distribut', 'therefor', 'use', 'Z', 'score', 'evalu', 'whether', 'entiti', 'signific', 'specif', 'text', 'use', 'Z', 'score', 'cutoff', 'valu', 'addit', 'entiti', 'singular', 'plural', 'noun', 'form', 'synonym', 'multipl', 'form', 'abstract', 'therefor', 'number', 'subject', 'relat', 'entiti', 'automat', 'combin', 'noun', 'plural', 'form', 'homolog', 'word', 'adject', 'adverb', 'root', 'entiti', 'assign', 'number', 'figur', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'cshg', 'blue', 'node', 'repres', 'gene', 'interact', 'cshg', 'string', 'databas', 'combin', 'score', '800', 'red', 'squar', 'mark', 'relev', 'entiti', 'categori', 'cshg', 'right', 'reserv', 'reus', 'allow', 'without', 'permiss', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'yellow', 'node', 'repres', 'ace2', 'dpp4', 'ifitm1', 'gene', 'purpl', 'node', 'repres', 'gene', 'degre', 'interact', 'core', 'gene', 'green', 'circl', 'purpl', 'node', 'repres', 'gene', 'connect', 'cshg', 'C3', 'categori', 'relat', 'gene', 'pink', 'node', 'repres', 'gene', '2', 'degre', 'interact', 'core', 'gene', 'red', 'diamond', 'show', 'relev', 'entiti', 'categori', 'symbol', 'cshg', 'right', 'reserv', 'reus', 'allow', 'without', 'permiss', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'tabl', 'tabl', 'coronaviru', 'entiti', 'categori', 'label', 'gene', 'associ', 'categori', 'misc', 'indic', 'label', 'cannot', 'summar', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint']]\n"
     ]
    }
   ],
   "source": [
    "print(bodytext_list[0:1])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "2020-04-12 23:16:09.583578 \n",
      " 2020-04-12 23:16:29.454100 \n",
      " run_time = 0:00:19.870522\n"
     ]
    }
   ],
   "source": [
    "# not complete yet   \n",
    "# why 'list' object has no attribute 'lower' ???\n",
    "start = datetime.now() \n",
    "#tokenize the document after filtering \n",
    "tokens = [tokenizer.tokenize(str(i)) for i in bodytext] #tokenize words in lists\n",
    "\n",
    "# print(tokens)\n",
    "\n",
    "# remove stopwords, stemming and put word into list using \"for loop\"\n",
    "bodytext_list = []\n",
    "\n",
    "for w in tokens:\n",
    "    stopped = [i for i in w if str(i).lower() not in en_stop] #remove stop words\n",
    "    stemmed = [stemmer.stem(i) for i in stopped] #stem words\n",
    "    bodytext_list.append(stemmed) #append stemmed words to list\n",
    "    \n",
    "\n",
    "\n",
    "end = datetime.now()\n",
    "run_time = end-start\n",
    "print(start, \"\\n\",\n",
    "      end, \"\\n\",\n",
    "      'run_time =',run_time )\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "['sudden', 'outbreak', 'new', 'coronaviru', 'sar', 'cov', '2', 'end', 'decemb', '2019', 'pose', 'huge', 'threat', 'human', 'health', 'worldwid', 'sar', 'cov', '2', 'viru', 'caus', 'sever', 'respiratori', 'diseas', 'quickli', 'spread', 'person', 'person', 'case', 'lead', 'death', 'research', 'found', 'new', 'sar', 'cov', '2', 'sar', 'coronavirus', 'invad', 'human', 'cell', 'target', 'tissu', 'similar', 'manner', 'via', 'high', 'affin', 'bind', 'angiotensin', 'convert', 'enzym', '2', 'ace2', 'recent', 'epidemiolog', 'investig', 'spread', 'sar', 'cov', '2', 'preliminari', 'studi', 'clinic', 'characterist', 'diseas', '2', 'research', 'found', 'patient', 'infect', 'new', 'coronaviru', 'sever', 'symptom', 'similar', 'sar', 'infect', 'first', 'batch', 'clinic', 'data', 'report', 'sar', 'cov', '2', 'infect', 'case', 'china', 'reveal', 'cytokin', 'storm', 'critic', 'ill', 'patient', 'howev', 'mechan', 'viral', 'infect', 'patholog', 'chang', 'immun', 'system', 'still', 'lack', 'sooner', 'inform', 'ad', 'current', 'clinic', 'knowledg', 'virus', 'better', 'control', 'treatment', 'diseas', 'present', 'autom', 'topic', 'wise', 'infer', 'method', 'call', 'twirl', 'topic', 'wise', 'infer', 'engin', 'massiv', 'biomed', 'literatur', 'process', 'massiv', 'biomed', 'literatur', 'summar', 'coronaviru', 'host', 'relat', 'entiti', 'twirl', 'capabl', 'collect', 'classifi', 'analyz', 'report', 'coronaviru', 'studi', 'reveal', 'entiti', 'base', 'distribut', 'specif', 'gene', 'text', 'articl', 'combin', 'gener', 'protein', 'interact', 'data', 'link', 'certain', 'function', 'cellular', 'physiolog', 'compon', 'infer', 'fill', 'knowledg', 'gap', 'probabl', 'mechan', 'host', 'patholog', 'chang', 'eventu', 'lead', 'acut', 'lung', 'injuri', 'host', 'therefor', 'twirl', 'use', 'guid', 'human', 'research', 'provid', 'potenti', 'therapeut', 'target', 'inform', 'treatment', 'acut', 'viral', 'lung', 'injuri', 'base', 'regul', 'ra', 'coronaviru', 'studi', 'specif', 'entiti', 'host', 'gene', 'februari', '2020', 'pubm', 'databas', 'includ', '878', 'biomed', 'articl', 'coronavirus', 'obtain', 'text', 'data', 'call', 'local', 'sampl', 'relat', 'articl', 'coronaviru', 'peer', 'review', 'publish', 'human', 'expert', 'includ', 'titl', 'abstract', 'author', 'affili', 'inform', 'total', '182', '687', 'word', 'goal', 'literatur', 'mine', 'identifi', 'host', 'gene', 'entiti', 'relev', 'coronaviru', 'research', 'establish', 'connect', 'entiti', 'refer', 'word', 'phrase', 'concept', 'name', 'includ', 'relat', 'concept', 'e', 'g', 'viru', 'structur', 'chemic', 'composit', 'sourc', 'infect', 'viru', 'type', 'gene', 'name', 'defin', 'use', 'mammalian', 'offici', 'gene', 'symbol', 'hugo', 'gene', 'name', 'committe', 'hgnc', 'databas', 'directli', 'retriev', '667', 'candid', 'gene', 'local', 'sampl', 'establish', 'random', 'distribut', 'one', 'candid', 'gene', 'control', 'sampl', 'signific', 'gene', 'appear', 'local', 'sampl', 'determin', 'frequenc', 'current', 'gene', 'outlier', 'random', 'distribut', 'control', 'sampl', 'see', 'method', 'detail', 'calcul', 'odd', 'ratio', 'also', 'determin', 'specif', 'associ', 'gene', 'local', 'sampl', 'paper', 'select', 'odd', 'ratio', 'threshold', 'judgment', 'result', '123', 'coronaviru', 'studi', 'specif', 'host', 'gene', 'cshg', 'determin', 'specif', 'entiti', 'made', 'choic', 'differ', 'text', 'local', 'sampl', 'remov', 'number', 'symbol', 'verb', 'garbl', 'charact', 'obtain', 'clean', 'version', 'local', 'sampl', 'coronaviru', 'studi', 'specif', 'entiti', 'csse', 'identifi', 'clean', 'text', 'contain', 'cshg', 'base', 'clean', 'select', 'sampl', 'next', 'built', 'local', 'dictionari', 'candid', 'css', 'contain', '293', 'word', 'dedupl', 'calcul', 'random', 'distribut', 'entiti', 'includ', 'synonym', 'entiti', 'entiti', 'number', 'includ', 'singular', 'plural', 'word', 'activ', 'passiv', 'form', 'differ', 'tens', 'suffix', 'chang', 'mean', 'etc', 'exampl', 'synonym', 'entiti', 'coronavir', 'coronaviru', 'coronavirus', 'group', 'one', 'entiti', 'coronaviru', 'assign', 'number', 'see', 'entiti', 'number', 'tabl', 'S1', 'sheet', 'first', 'column', 'previou', 'method', 'merg', 'synonym', 'entiti', 'base', 'dictionari', 'reli', 'integr', 'dictionari', 'also', 'requir', 'long', 'retriev', 'time', 'automat', 'solv', 'synonym', 'entiti', 'problem', 'twirl', 'classifi', 'similar', 'string', 'base', 'whether', 'signific', 'statist', 'associ', 'charact', 'block', 'set', 'candid', 'entiti', 'includ', 'variou', 'synonym', 'entiti', 'see', 'method', 'clean', 'process', 'css', 'identifi', 'twirl', 'use', 'similar', 'method', 'cshg', 'describ', 'candid', 'csse', 'dictionari', 'random', 'distribut', 'model', 'entiti', 'built', 'twirl', 'use', 'control', 'sampl', 'identifi', '623', 'css', 'tabl', 'Sl', 'sheet', 'base', 'outlier', 'discrimin', 'random', 'model', 'calcul', 'odd', 'ratio', 'exampl', 'twirl', 'found', 'css', 'close', 'ace2', 'receptor', 'sar', 'sar', 'cov', '2', 'virus', 'see', 'left', 'panel', 'figur', 'size', 'entiti', 'repres', 'rel', 'distanc', 'ace2', 'larger', 'size', 'indic', 'closer', 'distanc', 'ace2', 'addit', 'present', 'csse', 'cloud', 'human', 'receptor', 'gene', 'dpp4', 'mer', 'viru', 'see', 'right', 'panel', 'figur', 'although', 'twirl', 'identifi', '623', 'css', 'collat', 'human', 'research', 'inform', 'scatter', 'word', 'limit', 'reconstruct', 'understand', 'mechanist', 'model', 'therefor', 'twirl', 'cluster', 'css', 'accord', 'rule', 'defin', 'cshg', 'distribut', 'genet', 'level', 'research', 'accur', 'answer', 'solv', 'physiolog', 'patholog', 'problem', 'twirl', 'first', 'calcul', 'specif', 'co', 'distribut', 'cshg', 'local', 'sampl', 'determin', 'distanc', 'pair', 'css', 'perform', 'dichotomi', 'cluster', 'accord', 'linkag', 'relationship', 'css', 'cshg', 'classifi', '623', 'entiti', 'categori', 'repres', 'C0', 'c31', 'see', 'categori', 'number', 'tabl', 'S1', 'sheet', 'second', 'column', 'addit', 'categori', 'twirl', 'also', 'cite', 'top', 'ten', 'relev', 'refer', 'human', 'research', 'tabl', 'S2', 'therefor', 'categori', 'accord', 'csse', 'relev', 'literatur', 'quickli', 'provid', 'label', 'conclus', 'drawn', 'human', 'research', 'HR', 'label', 'categori', 'label', 'outlin', 'relev', 'research', 'direct', 'current', 'entiti', 'categori', 'exampl', 'categori', 'C3', 'HR', 'label', 'neurotroph', 'coronaviru', 'relat', 'immun', 'mediat', 'demyelin', 'summar', 'HR', 'label', 'entiti', 'categori', 'tabl', 'rel', 'posit', 'cshg', 'certain', 'csse', 'estim', 'twirl', 'see', 'tabl', 'S1', 'rank', 'matrix', 'sheet', 'categori', 'contain', 'differ', 'entiti', 'determin', 'whether', 'certain', 'cshg', 'significantli', 'closer', 'entiti', 'current', 'categori', 'base', 'rank', 'matrix', 'cshg', 'csse', 'exampl', 'averag', 'distanc', 'ace2', 'entiti', 'categori', 'C5', 'first', 'calcul', 'random', 'distribut', 'model', 'averag', 'distanc', 'ace2', 'entiti', '3000', '5000', 'time', 'built', 'final', 'determin', 'averag', 'distanc', 'ace2', 'entiti', 'categori', 'C5', 'significantli', 'less', 'deviat', 'mean', 'random', 'distribut', 'Z', 'score', '8416', 'signific', 'categori', 'associ', 'cshg', 'score', 'twirl', 'rang', 'smaller', 'score', 'indic', 'current', 'cshg', 'relev', 'current', 'categori', 'see', 'Z', 'score', 'matrix', 'tabl', 'S1', 'sheet', '2', 'entiti', 'categori', 'associ', 'cshg', 'e', 'g', 'Ci', 'cshg', 'repres', 'categori', 'number', 'thu', 'select', 'Z', 'score', 'Z', 'score', 'describ', 'associ', 'cshg', 'categori', 'summar', 'sheet2', 'tabl', 'S1', 'categori', 'label', 'cshg', 'provid', 'sheet', 'specif', 'spike', 'protein', 'protein', 'differ', 'coronavirus', 'recogn', 'differ', 'receptor', 'molecul', 'human', 'cell', 'ace2', 'bind', 'spike', 'protein', 'sar', 'sar', 'cov', '2', 'viru', 'dpp4', 'bind', 'spike', 'protein', 'mer', 'viru', 'found', 'two', 'gene', 'assign', 'C5', 'categori', 'correspond', 'HR', 'label', 'spike', 'protein', 'coronaviru', 'suggest', 'twirl', 'automat', 'provid', 'interfac', 'summar', 'human', 'find', 'help', 'human', 'expert', 'quickli', 'understand', 'research', 'direct', 'necessari', 'knowledg', 'field', 'distribut', 'mean', 'data', 'compar', 'specif', 'express', 'valu', 'cshg', 'differ', 'condit', 'categori', 'use', 'condit', 'therefor', 'base', 'right', 'reserv', 'reus', 'allow', 'without', 'permiss', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'distribut', 'pathway', 'signatur', 'twirl', 'recommend', 'like', 'least', 'like', 'signal', 'pathway', 'tabl', '2', 'hand', 'twirl', 'also', 'recommend', 'like', 'least', 'like', 'categori', 'signal', 'pathway', 'exampl', 'tabl', 'show', 'signal', 'pathway', 'like', 'associ', 'categori', 'C3', 'unlik', 'correspond', 'categori', 'coupl', 'data', 'gene', 'interact', 'regul', 'databas', 'construct', 'gener', 'protein', 'protein', 'interact', 'network', 'ppi', 'network', 'among', '119', 'gene', '123', 'cshg', 'defin', 'direct', 'interact', 'two', 'gene', 'degre', 'interact', 'indirect', 'interact', 'connect', 'two', 'gene', 'gene', '2', 'degre', '2', 'interact', 'gene', 'network', 'mine', 'ppi', 'databas', 'shown', 'figur', '2', 'result', 'dedupl', 'show', '2', '004', 'pair', '119', 'cshg', 'see', 'tabl', 'S1', 'sheet', 'control', 'averag', 'interact', '119', 'randomli', 'select', 'gene', 'databas', 'show', '252', '612', 'pair', 'averag', '220', 'standard', 'deviat', 'compar', 'random', 'gene', 'regulatori', 'connect', 'cshg', 'significantli', 'enrich', 'Z', 'score', '97', 'cshg', 'associ', 'certain', 'categori', 'much', 'closer', 'interact', 'exampl', 'cshg', 'associ', 'categori', 'C3', 'associ', 'C5', 'c10', 'closer', 'network', 'figur', '2', 'suggest', 'twirl', 'possibl', 'highlight', 'import', 'research', 'direct', 'biolog', 'system', 'involv', 'coronaviru', 'specif', 'research', 'provid', 'reliabl', 'interfac', 'automat', 'infer', 'sever', 'hub', 'gene', 'among', '119', 'cshg', 'recommend', 'twirl', 'compar', 'random', 'sampl', 'interact', 'record', 'databas', 'hub', 'gene', 'significantli', 'increas', 'number', 'interact', '118', 'cshg', 'recommend', 'result', 'show', 'three', 'member', 'ifitm', 'famili', 'ifitm1', 'rank', 'first', 'second', 'sixth', 'among', 'top', 'ten', 'hub', 'gene', 'csse', 'cloud', 'ifitm', 'famili', 'gene', 'shown', 'figur', 'detail', 'rank', 'recommend', 'result', 'shown', 'tabl', 'S1', 'sheet', 'ifitm', 'gene', 'show', '115', 'interact', 'account', '338', 'interact', '119', 'cshg', 'ifitm', 'significantli', 'enrich', 'local', 'sampl', 'repres', 'updat', 'coronaviru', 'relat', 'right', 'reserv', 'reus', 'allow', 'without', 'permiss', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'studi', 'averag', '03', 'control', 'test', 'random', 'sampl', 'p', '5676e', 'ifitm', 'famili', 'play', 'crucial', 'role', 'induct', 'interferon', 'viral', 'infect', 'action', 'interferon', 'ifitm', 'disrupt', 'intracellular', 'cholesterol', 'homeostasi', 'prevent', 'viru', 'enter', 'host', 'cell', 'howev', 'twirl', 'directli', 'associ', 'ifitm', 'categori', 'need', 'provid', 'inform', 'twirl', 'determin', 'part', 'gene', 'might', 'involv', 'coronaviru', 'infect', 'host', 'bodi', 'respons', 'combin', 'gener', 'interact', 'databas', 'provid', 'richer', 'interact', 'regulatori', 'linkag', 'extend', '119', 'cshg', '2', 'network', 'base', 'interact', 'higher', 'likelihood', 'connect', 'combin', 'score', '800', '2', 'network', 'expand', 'number', 'gene', '119', 'host', 'gene', '494', 'gene', 'may', 'associ', 'coronaviru', 'see', 'tabl', 'S1', 'sheet', 'dpp4', 'differ', 'distribut', 'receptor', 'respiratori', 'tract', 'result', 'differ', 'degre', 'infect', 'although', 'infect', 'abil', 'mer', 'lower', 'sar', 'mortal', 'higher', 'one', 'third', 'patient', 'deeper', 'infect', 'site', 'similar', 'sar', 'viru', 'viral', 'genom', 'structur', 'biolog', 'studi', 'shown', 'ace2', 'also', 'function', 'receptor', 'new', 'sar', 'cov', '2', 'coronaviru', 'bind', 'ace2', 'via', 'spike', 'protein', 'sar', 'cov', '2', 'undergo', 'membran', 'fusion', 'enter', 'host', 'cell', 'endocytosi', 'ace2', 'peptidas', 'key', 'regul', 'renin', 'angiotensin', 'system', 'ra', 'highli', 'express', 'heart', 'kidney', 'testi', 'also', 'express', 'lower', 'level', 'tissu', 'mainli', 'intestin', 'lung', 'recent', 'studi', 'shown', 'bind', 'protein', 'ace2', 'new', 'coronaviru', '20', 'time', 'stronger', 'sar', 'viru', 'may', 'help', 'new', 'coronaviru', 'infect', 'host', 'upper', 'respiratori', 'tract', 'significantli', 'increas', 'infect', 'use', 'twirl', 'abl', 'identifi', 'ace2', 'dpp4', 'gene', 'cshg', 'significantli', 'associ', 'C5', 'categori', 'HR', 'label', 'categori', 'associ', 'protein', 'addit', 'ace2', 'dpp4', 'cshg', 'significantli', 'associ', 'C5', 'categori', 'includ', 'furin', 'tmprss2', 'former', 'may', 'requir', 'h7n1', 'h5n1', 'influenza', 'viru', 'infect', 'probabl', 'via', 'hemagglutinin', 'induc', 'lysi', 'wherea', 'latter', 'wide', 'report', 'mediat', 'assist', 'invas', 'host', 'cell', 'multipl', 'virus', 'transmembran', 'proteas', 'serin', '2', 'tmprss2', 'serin', 'proteas', 'hydrolyz', 'activ', 'spike', 'glycoprotein', 'human', 'coronaviru', '229e', 'hcov', '229e', 'human', 'coronaviru', 'emc', 'hcov', 'emc', 'sendai', 'viru', 'sev', 'human', 'interstiti', 'pneumoviru', 'hmpv', '2', 'fusion', 'glycoprotein', 'F0', '4a', '4b', 'human', 'parainfluenza', 'virus', 'hpiv', 'function', 'gene', 'essenti', 'transmiss', 'pathogenesi', 'influenza', 'virus', 'h1n1', 'h3n2', 'h7n9', 'strain', 'also', 'involv', 'hydrolysi', 'activ', 'hemagglutinin', 'protein', 'essenti', 'viral', 'infect', '20', 'although', 'entiti', 'C5', 'categori', 'cite', 'literatur', 'mainli', 'show', 'viru', 'invas', 'facilit', 'viru', 'bind', 'receptor', 'membran', 'proteas', 'biolog', 'mechan', 'receptor', 'bind', 'virus', 'lead', 'patholog', 'chang', 'report', 'less', 'frequent', 'right', 'reserv', 'reus', 'allow', 'without', 'permiss', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'twirl', 'recommend', 'new', 'gene', 'interact', 'C5', 'cshg', '2', 'csgh', 'link', 'gene', 'might', 'enrich', 'categori', 'infer', 'base', 'process', 'find', 'new', 'gene', 'connect', 'differ', 'categori', 'connect', 'categori', 'suggest', 'potenti', 'regulatori', 'relationship', 'differ', 'biolog', 'function', 'phenotyp', 'gene', 'serv', 'linker', 'potenti', 'target', 'gain', 'loss', 'function', 'experi', 'identifi', 'system', 'describ', 'meaning', 'entiti', 'categori', 'paper', 'twirl', 'found', '2', 'network', 'show', 'connect', 'certain', 'cshg', 'associ', 'categori', 'categori', 'exampl', 'twirl', 'found', 'cshg', '2', 'connect', 'ifitm1', 'mainli', 'concentr', 'C3', 'categori', 'see', 'figur', 'interestingli', 'cshg', '2', 'connect', 'ace2', 'dpp4', 'associ', 'C5', 'categori', 'also', 'enrich', 'C3', 'categori', 'infer', 'inform', 'summar', 'C3', 'categori', 'probabl', 'describ', 'underli', 'mechan', 'patholog', 'chang', 'coronaviru', 'infect', 'analysi', 'signal', 'pathway', 'C3', 'mainli', 'ra', 'vitamin', 'rxr', 'activ', 'chemokin', 'signal', 'ra', 'signific', 'shown', 'tabl', 'summar', 'C3', 'relat', 'signal', 'pathway', 'link', 'C3', 'associ', 'cytokin', 'includ', 'ccl5', 'cxcl1', 'cxcl10', 'cxcl11', 'cxcl2', 'cxcl9', 'cxcr2', 'cxcr3', 'figur', 'subsequ', 'linker', 'gene', 'may', 'contain', 'inform', 'biolog', 'mechan', 'may', 'import', 'understand', 'diseas', 'exampl', 'twirl', 'recommend', 'angiotensinogen', 'agt', 'angiotensin', 'II', 'receptor', 'type', '2', 'agtr2', 'at2r', 'gene', 'C3', 'categori', 'associ', 'ace2', 'support', 'ra', 'probabl', 'involv', 'patholog', 'chang', 'caus', 'cytokin', 'storm', 'protein', 'bind', 'ace2', 'suggest', 'report', 'next', 'use', 'twirl', 'calcul', '2', 'network', '119', 'cshg', 'base', 'significantli', 'enrich', 'categori', 'cshg', 'network', 'twirl', 'separ', 'construct', 'model', 'complex', 'relationship', 'cshg', 'found', 'right', 'reserv', 'reus', 'allow', 'without', 'permiss', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'cshg', 'network', 'associ', 'C3', 'c10', 'categori', 'five', 'gene', 'ccl3', 'ccl5', 'cxcl1', 'cxcl2', 'stat2', 'associ', 'suggest', 'biolog', 'mechan', 'describ', 'C3', 'c10', 'categori', 'might', 'univers', 'involv', 'research', 'entiti', 'gene', 'pathway', 'linker', 'gene', 'particip', 'C3', 'c10', 'categori', 'could', 'lead', 'new', 'direct', 'prevent', 'treatment', 'clinic', 'manag', 'coronaviru', 'infect', 'studi', 'use', 'twirl', 'machin', 'base', 'approach', 'collect', 'summar', 'analyz', '000', 'biomed', 'articl', 'relat', 'coronaviru', 'aim', 'elucid', 'mechan', 'underli', 'coronaviru', 'induc', 'host', 'patholog', 'chang', 'use', 'twirl', 'found', 'possibl', 'mechan', 'involv', 'ace2', 'at2r', 'ra', 'cytokin', 'signal', 'becom', 'imbalanc', 'viru', 'infect', 'lead', 'cytokin', 'storm', 'twirl', 'system', 'autom', 'process', 'summar', 'entiti', 'gene', 'specif', 'relat', 'coronavirus', 'combin', 'system', 'gener', 'interact', 'databas', 'reveal', 'associ', 'provid', 'deeper', 'understand', 'biolog', 'mechan', 'diseas', 'phenotyp', 'caus', 'viru', 'host', 'interact', 'viru', 'ace2', 'may', 'disrupt', 'balanc', 'caus', 'steadi', 'state', 'imbal', 'ra', 'lead', 'subsequ', 'patholog', 'chang', 'although', 'ang', 'II', 'origin', 'describ', 'effect', 'vasoconstrictor', 'grow', 'evid', 'close', 'involv', 'inflammatori', 'respons', 'immun', 'system', 'pro', 'inflammatori', 'cytokin', 'deriv', 'immun', 'cell', 'normal', 'regul', 'ra', 'compon', 'acceler', 'format', 'system', 'local', 'ang', 'II', 'particular', 'pro', 'inflammatori', 'cytokin', 'regul', 'product', 'agt', 'liver', 'kidney', 'hand', 'ra', 'also', 'implic', 'mediat', 'cytokin', 'storm', 'function', 'relationship', 'immun', 'system', 'angiotensin', 'II', 'regul', 'vascular', 'tension', 'stimul', 'releas', 'pro', 'inflammatori', 'cytokin', 'product', 'releas', 'cxc', 'chemokin', 'induc', 'accumul', 'neutrophil', 'vivo', 'meanwhil', 'ace', 'inhibitor', 'ang', 'II', 'receptor', 'blocker', 'use', 'number', 'cytokin', 'mediat', 'inflammatori', 'patholog', 'at1r', 'blocker', 'angiotensin', 'receptor', 'blocker', 'shown', 'benefici', 'effect', 'commonli', 'attribut', 'at2r', 'activ', 'time', 'report', 'ang', 'II', 'stimul', 'human', 'endotheli', 'cell', 'increas', 'releas', 'cxc', 'chemokin', 'IP', 'ifn', 'induc', 'protein', 'IP', 'cxcl10', 'mainli', 'express', 'lung', 'chemoattract', 'activ', 'cell', 'express', 'IP', 'observ', 'mani', 'th1', 'type', 'inflammatori', 'diseas', 'thought', 'play', 'import', 'role', 'recruit', 'activ', 'cell', 'site', 'tissu', 'inflamm', 'therefor', 'ra', 'dysfunct', 'may', 'result', 'accumul', 'cytokin', 'lung', 'lead', 'excess', 'accumul', 'immun', 'cell', 'interstiti', 'fluid', 'block', 'airway', 'caus', 'eventu', 'death', 'report', 'first', 'sever', 'infect', 'patient', 'diagnos', 'covid', 'larg', 'number', 'patient', 'experienc', 'cytokin', 'storm', 'fatal', 'figur', 'summar', 'function', 'chang', 'patholog', 'consequ', 'ra', 'system', 'ace2', 'combin', 'coronaviru', 'expect', 'mechan', 'summar', 'reason', 'twirl', 'support', 'patholog', 'evid', 'date', 'one', 'report', 'post', 'mortem', 'biopsi', 'publish', 'patholog', 'data', 'although', 'histolog', 'examin', 'show', 'bilater', 'diffus', 'alveolar', 'damag', 'cellular', 'fibromyxoid', 'exud', 'right', 'lung', 'show', 'evid', 'desquam', 'right', 'reserv', 'reus', 'allow', 'without', 'permiss', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'pneumocyt', 'hyalin', 'membran', 'format', 'indic', 'acut', 'respiratori', 'distress', 'syndrom', 'ard', 'wherea', 'left', 'lung', 'show', 'pulmonari', 'edema', 'hyalin', 'membran', 'format', 'suggest', 'earli', 'phase', 'ard', 'patholog', 'evid', 'suggest', 'ard', 'symptom', 'close', 'relat', 'cytokin', 'storm', 'howev', 'still', 'lack', 'histopatholog', 'relat', 'data', 'support', 'preliminari', 'find', 'gener', 'machin', 'approach', 'right', 'reserv', 'reus', 'allow', 'without', 'permiss', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprintw', 'use', 'pubm', 'wide', 'use', 'databas', 'biolog', 'literatur', 'resourc', 'text', 'mine', 'schemat', 'represent', 'overal', 'studi', 'design', 'shown', 'figur', 'summar', 'follow', 'step', 'dataset', 'use', 'pipelin', 'pubm', 'articl', 'first', 'pubm', 'search', 'articl', 'includ', 'titl', 'abstract', 'author', 'affili', 'inform', 'contain', 'subject', 'keyword', 'coronaviru', 'search', 'result', 'download', 'txt', 'format', 'compil', 'structur', 'inform', 'text', 'subject', 'abstract', 'set', 'organ', 'clean', 'assign', 'specif', 'corpus', 'relat', 'coronaviru', 'specif', 'corpu', 'compil', 'subject', 'dictionari', 'enhanc', 'accuraci', 'effect', 'entiti', 'associ', 'keyword', 'use', 'random', 'corpu', 'comparison', 'search', 'articl', 'abstract', 'contain', 'keyword', 'public', 'health', 'compil', 'abstract', 'set', 'random', 'corpu', 'compil', 'random', 'control', 'dictionari', 'contain', 'wide', 'rang', 'protein', 'gene', 'relat', 'biolog', 'entiti', 'also', 'consid', 'balanc', 'amount', 'inform', 'set', 'relev', 'paramet', 'adjust', 'amount', 'text', 'carri', 'statist', 'analys', 'biolog', 'entiti', 'identif', 'key', 'step', 'literatur', 'mine', 'process', 'ensur', 'function', 'extract', 'entiti', 'first', 'compar', 'entiti', 'subject', 'dictionari', 'human', 'offici', 'gene', 'symbol', 'hugo', 'gene', 'nomenclatur', 'commiss', 'hgnc', 'databas', 'gener', 'subject', 'candid', 'gene', 'use', 'standard', 'nomenclatur', 'addit', 'entiti', 'abstract', 'capit', 'avoid', 'error', 'identif', 'process', 'obtain', 'wide', 'use', 'gene', 'entiti', 'precis', 'relat', 'subject', 'determin', 'signific', 'gene', 'distribut', 'specif', 'text', 'calcul', 'differ', 'distribut', 'proport', 'search', 'subject', 'candid', 'gene', 'subject', 'dictionari', 'random', 'control', 'dictionari', 'respect', 'also', 'count', 'number', 'abstract', 'contain', 'subject', 'candid', 'gene', 'abstract', 'set', 'respect', 'final', 'calcul', 'odd', 'ratio', 'subject', 'candid', 'gene', 'sort', 'list', 'precis', 'relat', 'gene', 'cshg', 'similar', 'process', 'identifi', 'cshg', 'calcul', 'whether', 'entiti', 'significantli', 'distribut', 'specif', 'corpu', 'count', 'number', 'text', 'contain', 'cshg', 'specif', 'corpu', 'count', 'number', 'candid', 'entiti', 'corpu', 'subset', 'next', 'randomli', 'select', 'amount', 'text', 'random', 'control', 'corpu', 'count', 'number', 'candid', 'entiti', 'subset', 'random', 'corpu', 'repeat', '10000', 'time', 'random', 'corpu', 'gener', 'candid', 'entiti', 'specifi', 'amount', 'text', 'random', 'distribut', 'model', 'accord', 'central', 'limit', 'theorem', 'clt', 'distribut', 'random', 'sampl', 'averag', 'randomli', 'distribut', 'data', 'alway', 'conform', 'normal', 'distribut', 'therefor', 'use', 'Z', 'score', 'evalu', 'whether', 'entiti', 'signific', 'specif', 'text', 'use', 'Z', 'score', 'cutoff', 'valu', 'addit', 'entiti', 'singular', 'plural', 'noun', 'form', 'synonym', 'multipl', 'form', 'abstract', 'therefor', 'number', 'subject', 'relat', 'entiti', 'automat', 'combin', 'noun', 'plural', 'form', 'homolog', 'word', 'adject', 'adverb', 'root', 'entiti', 'assign', 'number', 'figur', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'cshg', 'blue', 'node', 'repres', 'gene', 'interact', 'cshg', 'string', 'databas', 'combin', 'score', '800', 'red', 'squar', 'mark', 'relev', 'entiti', 'categori', 'cshg', 'right', 'reserv', 'reus', 'allow', 'without', 'permiss', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'yellow', 'node', 'repres', 'ace2', 'dpp4', 'ifitm1', 'gene', 'purpl', 'node', 'repres', 'gene', 'degre', 'interact', 'core', 'gene', 'green', 'circl', 'purpl', 'node', 'repres', 'gene', 'connect', 'cshg', 'C3', 'categori', 'relat', 'gene', 'pink', 'node', 'repres', 'gene', '2', 'degre', 'interact', 'core', 'gene', 'red', 'diamond', 'show', 'relev', 'entiti', 'categori', 'symbol', 'cshg', 'right', 'reserv', 'reus', 'allow', 'without', 'permiss', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint', 'tabl', 'tabl', 'coronaviru', 'entiti', 'categori', 'label', 'gene', 'associ', 'categori', 'misc', 'indic', 'label', 'cannot', 'summar', 'author', 'funder', 'grant', 'medrxiv', 'licens', 'display', 'preprint', 'perpetu', 'copyright', 'holder', 'preprint', 'peer', 'review', 'http', 'doi', 'org', '2020', '02', '20025437', 'doi', 'medrxiv', 'preprint']\n"
     ]
    }
   ],
   "source": [
    "print(bodytext_list[0])\n",
    "\n",
    "# bodytext_list_1 = [i.split() for i in bodytext_list] \n",
    "# bodytext_list_1\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "vect = CountVectorizer(tokenizer=tokenizer, stop_words = en_stop, ngram_range= (1,1),max_features = 2000)\n",
    "print(\"fit option has \\n\" ,vect.fit(bodytext_list))\n",
    "dtm3 = vect.transform(bodytext_list)\n",
    "final_df3 = pd.DataFrame(dtm.toarray(), columns=vect.get_feature_names())\n",
    "final_df3"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 6. Topic Extraction (opposite of Clusters, similar to PCA) cluster the column"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 7. Can clustering be done as the second step, after narrowing the scope using step 4?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [],
   "source": [
    "from sklearn.decomposition import SparsePCA\n",
    "from sklearn.preprocessing import StandardScaler\n",
    "from sklearn.ensemble import IsolationForest\n",
    "from sklearn.cluster import KMeans\n",
    "import matplotlib._color_data as mcd\n",
    "import matplotlib.pyplot as plt\n",
    "import seaborn as sns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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\n",
      "text/plain": [
       "<Figure size 1440x1080 with 1 Axes>"
      ]
     },
     "metadata": {
      "needs_background": "light"
     },
     "output_type": "display_data"
    }
   ],
   "source": [
    "#this part of code is take from Josh    #get differnt cluster because extend stop words list\n",
    "\n",
    "#### parameters #####\n",
    "contamination = .1\n",
    "n_clusters=8\n",
    "\n",
    "##### preserving data from previous step\n",
    "df_t = final_df\n",
    "df2_t = final_df2\n",
    "master_t = pd.concat([df_t.reset_index(),df2_t.reset_index()], axis=1)\n",
    "master_t = master_t.dropna()\n",
    "\n",
    "##### Droping Outliers \n",
    "master_t = pd.concat([df_t.reset_index(),df2_t], axis=1)\n",
    "clf = IsolationForest(n_jobs=-1, contamination=contamination)\n",
    "master_t['outliers']=clf.fit_predict(master_t.iloc[:,8:])\n",
    "master_t.iloc[:, 8:] = master_t[master_t.outliers == 1]\n",
    "master_t = master_t.dropna()\n",
    "\n",
    "##### Standardizing DF\n",
    "sc = StandardScaler()\n",
    "master_t.iloc[:,8:-1] = sc.fit_transform(master_t.iloc[:,8:-1] +.000001)\n",
    "pca=SparsePCA(n_components=2)\n",
    "pca_componenets = pca.fit_transform(master_t.iloc[:,8:-1])\n",
    "pca_componenets = pd.DataFrame(pca_componenets, columns=['comp_1', 'comp_2'])\n",
    "master_t=pd.concat([master_t.reset_index(),pca_componenets], axis=1)\n",
    "\n",
    "### Clustering\n",
    "from sklearn.cluster import KMeans\n",
    "clf = KMeans(n_clusters=n_clusters,n_jobs=-1)\n",
    "master_t['clusters'] = clf.fit_predict(master_t.iloc[:,-2:])\n",
    "\n",
    "\n",
    "### Grpahing \n",
    "plt.figure(figsize=(20,15))\n",
    "p1 = sns.scatterplot(master_t['comp_1'],master_t['comp_2'],data=master_t,size = 10,legend=False)  \n",
    "p1.set_title(\"Most Common Words in an Article by Cluster\")\n",
    "colors = [name for name in mcd.CSS4_COLORS if \"xkcd:\" + name in mcd.XKCD_COLORS]\n",
    "\n",
    "\n",
    "for title in range(10,master_t.shape[0]):\n",
    "  most_common=master_t.iloc[title, 9:-5].sort_values().index[-1]\n",
    "  p1.text(master_t.comp_1[title], master_t.comp_2[title], most_common, horizontalalignment='left', color=colors[master_t.clusters[title] * 3], size =10, weight='semibold')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### 8. How can Word2Vec be used? \n",
    "\n",
    "Choose 3 words and do W2V separate then see similarity for those 3 words.\n",
    "\n",
    "### 9. How can Sen2Vec be used? \n",
    "Bert(horsepower behind google), Doctor QA (Facebook)\n",
    "\n",
    "### 10. How can Doc2Vec be used?"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
